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1. Het percentage gefosforyleerd connexin43 in epidermale cellen correleert 
niet met het nivo van intercellulaire communicatie via gap junctions. 
Dit proefschrift. 
2. Zowel intracellulair calcium als extracellulair calcium kan een rol spelen 
in de remming van intercellulaire communicatie via gap junctions door 
tumor promotoren. 
Dit proefschrift. 
3. In het proces van tumorvorming kunnen veranderingen optreden in de 
regulatie van intercellulaire communicatie door calmoduline-afhankelijke 
processen. 
Dit proefschrift. 
4. Tumor promotoren kunnen naast een rol in de promotiefase van het 
proces van tumorvorming, ook een rol spelen in de progressiefase van 
tumorvorming. 
Dit proefschrift. 
5. De opvatting van Lucas en Wolf waarin een plasmodesma wordt 
gedefinieerd als 'intercellulair organeF breekt met de traditie dat een 
organel een subcellulair en cytoplasmatisch gelocaliseerd cellichaam is en 
is onjuist. 
Lucas W.J. and Wolf S. (1993) Trends in Cell Biology 3: 308-315. 
Darnell J. et al. (1990) Molecular cell Biology, 2nd ed. Scientific American Books, Freeman, 
New York. 
Esau K. (1977[1960]). Plant Anatomy, 2nd ed. Wiley & Sons, New York. 
6. De opvatting dat 'vertakte plasmodesmata' alleen een vorm zijn van 
'secundaire plasmodesmata' is onjuist en leidt tot misvattingen met 
betrekking tot het functioneren van primaire en secundaire 
plasmodesmata. 
Ding B. et al., (1992) Plant Cell 4: 915-928. 
Ehlers K. and Kollmann, R. (1996). Planta 199: 126-138. 
7. Gezien het belang van het goed functioneren van Mismatch Repair 
enzymen dienen, bij een toxicologische screening van verbindingen, mede 
effecten op het functioneren van deze enzymen bestudeerd te worden. 
Parsons R. et al. (1993) Cell 75: 1227-1236. 
8. In de gangbare opvatting over de oorzaken van een groot aantal ziektes 
wordt onevenredig veel nadruk gelegd op de genetische component. 
9. Een gebrekkige communicatie is mede oorzaak van veel problemen op 
alle mogelijke biologische integratie nivo's. 
10. Daar de fysieke gesteldheid van personen mede bepalend is voor hun 
geestelijke stabiliteit en incasseringsvermogen, dient in het 
onderwijsprogramma van onderzoeksscholen voor promovendi mede 240 
uur verplicht sporten te zijn opgenomen. 
11. De weigering van het adoptierecht voor homofiele paren is een 
overschatting van de kwaliteit van de traditionele "hoeksteen van de 
samenleving". 
Psychological Perspectives on Lesbian & Gay Mate Experiences. L.D.Garnets & 
D.C.Kimmel, New York, NY, Columbia University Press 1993, 421-457. 
12. Uit milieuoverwegingen dient de kinderbijslag vervangen te worden door 
een kinderbelasting. Met de opbrengst van deze gelden kan milieu-
besparend gedrag (o.a. kinderloosheid van paren) beloond worden. 
Stellingen behorende bij het proefschrift "Changing gap junctional intercellular 
communication in mouse epidermal cells during tumorigenesis: a study on 
underlying processes" 
Leon Jansen, 14 oktober 1996. 
Contents 
Chapter 1 
Chapter 2 
Chapter 3 
Abbreviations 
General Introduction 
Materials and Methods 
Differences in the calcium-mediated regulation of gap 
junctional intercellular communication between a cell line 
consisting of initiated cells and a carcinoma-derived cell 
line 
7 
9 
23 
29 
Chapter 4 Cyclic AMP-rnediated control of gap junctional 
intercellular communication is differentially regulated in 
initiated and carcinoma cells 
47 
Chapter 5 The use of initiated cells as a test system for the detection 
of inhibitors of gap junctional intercellular communication 
61 
Chapter 6 Inhibition of gap junctional intercellular communication 
and delocalization of the cell adhesion molecule E-
cadherin by tumor promoters 
77 
Chapter 7 Tumor promoters induce inhibition of gap junctional 
intercellular communication in mouse epidermal cells by 
affecting the localization of connexin43 and E-cadherin 
89 
Chapter 8 The role of calcium in the tumor promoter-induced 
inhibition of gap junctional intercellular communication 
103 
Chapter 9 
Chapter 10 
Appendix 
Summary and concluding remarks 
Samenvatting en slotopmerkingen 
Curriculum Vitae 
List of publications 
Dankwoord 
115 
119 
123 
124 
125 
Abbriviations 
Abbreviations 
ANOVA Analysis of variance 
BoP Benzoyl Peroxide 
Ca2+e Extracellular calcium 
Ca2+j Intracellular calcium 
CaM Calmodulin 
Ca/CaM-PK II Calcium/calmodulin-dependent protein kinase II 
Cx43 Connexin43 
DDT 1,1' -(2,2,2-trichloroethylidene)bis[4-chlorobenzene] 
DMB A 7,12-dimethylbenz [a] anthracene 
DMSO Dimethylsulfoxide 
EGTA-AM Ethylene glycol-bis(6-amino-ethyl ether)-n,n,n',n'-tetraacetic acid 
acetoxy-methyl ester 
GJIC Gap Junctional Intercellular Communication 
IB MX 3-isobuthyl-1 -methyl-xanthine 
ML-7 1 -(5 -iodonaphthalene-1 -sulfonyl)-1 H-hexahy dro-1,4-diazepine 
PB Phenobarbital 
PKA Protein kinase A 
PKC Protein kinase C 
REML Residual maximum likelihood 
Rpc AMP Rp-Adenosine-3' ,5' -cyclic-Monophosphate-triethylamine 
SDS Sodium dodecyl sulphate 
Spc AMP Sp-Adenosine-3' ,5' -cyclic-Monophosphate-triethylamine 
Tg Thapsigargin 
TPA 12-O-tetradecanoylphorbol-13-acetate 
W-7 N-(6-aminohexyl)-5-chloro-1 -naphthalene-sulfonamide 
Chapter 1 
General Introduction 
Chapter 1 
Framework of this study 
The study described in this thesis has been performed within the framework of an 
European study on the detection and working mechanisms of non-mutagenic 
carcinogens in a project of Science and Technology for Environmental Protection 
(STEP-program), partially financed by the Commission of European Communities 
(CEC). The work of this study has been carried out at the Agrotechnological Research 
Institute (ATO-DLO), Wageningen, The Netherlands, and at the International Agency 
for Research on Cancer (IARC), Lyon, France, in cooperation with the Department of 
Toxicology and the Department of Food Technology, both of the Agricultural 
University Wageningen, Wageningen, The Netherlands. 
The multistage process of tumor formation 
The terms initiation and promotion in the process of tumor formation were for the first 
time defined in the paper of Friedewald and Rous after applying a two-stage technique 
for the development of skin tumors in rabbits (1). Later on, in 1974, Boutwell et al. 
hypothesized that various stages could be distinguished within the process of chemical-
induced tumor formation. This model for the multistage process of carcinogenesis has 
been further specified, and shown to be also suitable for the processes involved in 
hepatocarcinogenesis (3). According to this model, tumor formation starts with the 
initiation phase, in which one or more stable carcinogen-induced DNA mutations take 
place. These mutations transform the phenotype of normal cells into preneoplastic 
(initiated) cells. During the following stage in the process (the promotion phase), 
initiated cells undergo processes leading to clonal expansion and the formation of 
premalignant lesions. In the final progression phase, some of these cells develop to 
malignant phenotypes and secondary tumors will be formed. Several events are 
possibly involved during the promotion stage, like inhibition of gap junctional 
intercellular communication (GJIC), selective cell proliferation, and altered cell 
differentiation. This thesis will focus on processes involved in the inhibition of gap 
junctional intercellular communication. 
Gap junctions 
Gap junctions are transmembrane cell specialisations (channels), permitting small 
molecules (less than 1000 Dalton) to pass to neighbouring cells (4). These channels are 
often found in (sterol rich) clusters in plasma membranes, called plaques (5). One gap 
junction consists of two connexons (one per cell), which in turn consists of 6 subunits, 
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called connexins (6). Several connexins with different molecular weight exist, and the 
name of the connexins is directly coupled to their molecular weight. For instance, 
connexins with a molecular weight of 43 kDa are named connexin43 (Cx43). Currently 
12 different connexins have been described (7). The expression of the connexins is 
tissue-dependent and also dependents on the developmental stage of the tissue. More 
types of connexins can be expressed at a specific points in time in one cell type. The 
connexons formed by two identical sets of connexins can form functional channels 
(homologous communication). In addition, gap junctions can also be formed between 
cells expressing different types of connexins (heterologous communication), although 
the conductance is often less compared to homologous communication (8). 
Evidence for a role of GJIC in the process of tumor formation 
Several lines of evidence support a role for (inhibition of) GJIC in the process of tumor 
formation. First of all, generally the level of GJIC appears to be lower between cancer 
cells compared to the GJIC level between normal cells in vivo (9,10). Secondly, 
several agents with tumor promoter capacity in vivo, have been shown to decrease 
GJIC in several cell types (11,12). Thirdly, expression of several oncogenes can inhibit 
GJIC (13). In the fourth place, the growth of transformed cells can be inhibited by the 
stimulation of GJIC between these cells and non-transformed cells (14), and by 
transfection of transformed cells with a gene coding for a connexin (15). Finally, 
agents with an inhibitory effect on tumor formation can stimulate GJIC (16,17), and 
inhibition of GJIC by tumor promoters can be counteracted by these agents (17,18). 
All these data support the notion that inhibition of GJIC, and changes in the regulation 
of GJIC, plays a role in the process of tumor formation. 
Regulation of GJIC 
Theoretically, the level of GJIC can be influenced at different levels. First of all, in 
principle, the functioning of connexins could be affected by mutations of the connexin 
gene. However, this has only been reported for Cx32 in humans with the so-called 
Charcot-Marie-Tooth neuropathy (19). Secondly, connexin levels may be regulated on 
the transcriptional level, as was shown for the tumor promoter phenobarbital, which 
decreased the amount of Cx32 mRNA in livers (20). Thirdly, the GJIC level can be 
regulated by mechanisms controlling the localization of Cx protein. It has been 
reported by several groups, that treatment of cells with GJIC-inhibiting agents resulted 
in a decreased immunostaining of connexin on the plasma membrane (21,22). Finally, 
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the functioning of connexins can be regulated posttranslationally, i.e. by binding of 
intracellular proteins to connexins (23) or by phosphorylation of connexins (24). 
Phosphorylation of connexins could change the permeability of the gap junction by a 
shift in the tertiary structure of the connexins within one connexon. Furthermore, 
phosphorylation of connexins is supposed to be involved in the assembly of connexins 
in the plasma membrane (24), although this is not always the case (25). 
Posttranslational regulation of connexins could be triggered by different 
intracellular second messengers, such as Ca2+ and cAMP (Fig.l). The extracellular 
calcium concentration ([Ca2+]e) in mammalian cells is approximately 10" times higher 
compared to the intracellular calcium concentration ([Ca2+]j), which is about 100 nM. 
Cells maintain their low [Ca2+]; by pumping Ca2+ against the concentration gradient to 
the extracellular space, or into intracellular calcium stores (26). It has been reported 
that changes in [Ca2+]c and [Ca2+]j can affect the GJIC level in several cell types. The 
increase of extracellular calcium concentrations from 0.05 mM to 1.20 mM have been 
reported to stimulate GJIC in mouse papilloma- or carcinoma-derived cell lines up to 
6 hours after changing [Ca2+]e concentration, but not in primary keratinocytes or a cell 
line consisting of initiated cells (27). In addition, 2 mM Ca2+e has been shown to 
decrease GJIC in primary keratinocytes after 72 hours in these conditions (28), whereas 
a decreased [Ca2+]e (to 0.05 mM) inhibited GJIC in human keratinocytes (29). 
Concerning changes in [Ca2+];, a decreased GJIC was reported in bovine lens 
cell cultures (30), in salivary gland cells (31), and in hepatoma cells (32) when the 
intracellular calcium concentration ([Ca2+];) was increased. The [Ca2+]; can be increased 
1) by an increased influx over the plasma membrane; 2) by inhibition of the activity 
of the Ca2+ pumps; 3) as a result of specific intracellular signals like binding of inositol 
1,4,5-trisphosphate to receptors on intracellular calcium stores (26). Ca2+S can exert its 
effect by activation of the calcium-binding molecule calmodulin (CaM), which was 
shown to bind to connexin proteins (23). Indeed, CaM antagonists have been reported 
to increase the GJIC level (33). Furthermore, inhibition of GJIC by several tumor 
promoting agents can be counteracted by inhibition of CaM (34). This could be the 
result of stimulation of a Ca27CaM-dependent protein kinase (Ca27CaM-PK), which 
can phosphorylate connexin proteins (35). 
12 
Introduction 
Ca". 
Cx43 
f 
E-cadherin 
phosphorylation 
A 
? 
PKC 
Ca/CaM-PK 
PKA 
Figure 1: Possible regulation routes of GJIC initiated by a changed [Ca2+]e. See the text for explanation of 
the figure. 
Another intracellular signalling molecule involved in the regulation of GJIC is 
cAMP. This component is synthesized from ATP by the plasma membrane-bound 
enzyme adenylate cyclase, and is rapidly degraded by cAMP phosphodiesterases, 
whose activity is CaM-dependent (36). Increases of the cAMP concentration have been 
reported to increase GJIC levels in several cell types, on the contrary in other cells it 
had no effect on GJIC levels (37). The regulation of GJIC by cAMP is most probably 
due to the activation of cAMP-dependent protein kinase A (PKA), which has been 
shown to phosphorylate connexins (35). Besides Ca27CaM-PK and PKA, evidence for 
a role of the Ca2+- and lipid-dependent protein kinase C (PKC) in the regulation 
(inhibition) of GJIC has been shown (38). Finally, GJIC can be regulated by activation 
of tyrosine kinase. Activation of the src oncogene led to inhibition of GJIC in addition 
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with phosphorylation of connexin proteins on tyrosine residues (39). All these data 
support the hypothesis that in the regulation of GJIC several signal transduction routes 
are involved which lead to changes in phosphorylation levels of gap junction proteins. 
GJIC and cell adhesion 
Cell adhesion molecules are cell type specific molecules which are integral 
plasma membrane proteins and facilitate binding to other cells or to the extracellular 
matrix. The binding of a cell adhesion molecule to the same molecule of an adjacent 
cell could decrease the intercellular space, hereby facilitating the formation of other 
intercellular connections like tight junctions or gap junctions. 
Several kinds of cell adhesion molecules exist, which are classified into several distinct 
and structurally diversified families, including integrins, adhesion molecules of the Ig 
superfamily, LEC-CAMs, cadherins, and others (40). The cadherins are one of the most 
important molecules in the cell adhesion between epidermal cells. Currently eight types 
of cadherins can be distinguished: E-cadherin (also known as uvomorulin, L-CAM, arc-
1, and cell CAM 120/80), N-cadherin (also known as A-CAM or N-Cal CAM), P-
cadherin, R-cadherin, EP-cadherin, B-cadherin, T-cadherin, and M-cadherin (41). 
Cadherins are transmembrane molecules with two extracellular calcium binding sites 
which are essential for (Ca2+e-dependent) adhesion to the cadherin molecule of a 
neighbouring cell (42). How cadherins regulate GJIC is still unknown. Binding to 
cadherins of the adjacent cell might result in a decreased intercellular space, facilitating 
the possibility for connexons of neighbouring cells to form functional gap junctions. 
Furthermore, a cadherin binding-activated signal transduction route as suggested for 
integrins might also be possible (43). Several proteins were found to bind 
intracellularly to E-cadherin. These proteins (called catenins) connect E-cadherin to the 
cytoskeleton and the binding of these proteins has been shown to be crucial for E-
cadherin mediated cell adhesion (44). Furthermore, phosphorylation of 6-catenin on 
tyrosine residues may regulate E-cadherin functioning (45), suggesting a role of 
phosphorylation in the regulation of GJIC by E-cadherin. Finally, the function of cell 
adhesion molecules was shown to be regulated by protein kinase C, an enzyme with 
GJIC decreasing activity (46). 
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Cell culture assays based on inhibition of GJIC for the detections of agents with 
tumor promoting capacity 
Many tumor promoters have the capacity to decrease the level of GJIC between cells. 
Therefore, the observation of effects on GJIC could be a useful assay to detect tumor 
promoting agents. Two types of assays are used mostly for the detection of agents with 
GJIC inhibiting capacity: 1) metabolic cooperation assays involving exchange of 
precursors of nucleic acid synthesis between cells, 2) dye transfer assays to measure 
the passage of a fluorescent dye to adjacent cells. The sensitivity for the detection of 
agents with tumor promoting capacity in vivo is about 60% for both types of assays 
(12). Besides these two assays, several other assays have been developed to study 
effects of tumor promoting agents on a molecular level (Table 1). Mainly, the 
following types of cells or cell lines are used in these assays: V79 (Chinese hamster 
lung fibroblasts), 3T3 cells (fibroblasts), mouse or rat hepatocytes, mouse epidermal 
cell lines or human teratocarcinoma cells. These cells could be less sensitive to effects 
of tumor promoters on GJIC compared to initiated cells, because of the fact that in the 
process of tumor formation, initiated cells are the target cells for tumor promoting 
agents. Furthermore, these cell types could differ in the biotransformation capacity of 
xenobiotics. Indeed, it is shown that preneoplastic hepatocytes are more sensitive to 
inhibition of GJIC than primary hepatocytes (63). However, a detailed study on effects 
of tumor promoters on GJIC in cells representing different stages of tumor formation 
has not yet been reported. 
Objectives and approach of the studies in this thesis 
As shown by the study of Jongen et al. (1991), differences exist in the level of GJIC 
between cells representing different stages of the process of tumor formation. Under 
low Ca2+e conditions (0.05 mM), the GJIC level in a carcinoma-derived cell line 
(CA3/7) was much lower compared to the GJIC levels of a cell line consisting of 
initiated cells (3PC) or primary keratinocytes. When [Ca2+]e was increased to 1.20 mM, 
the GJIC level in CA3/7 cells increased to the same (high) GJIC level of primary 
keratinocytes and 3PC cells. How a changed [Ca2+]e affects GJIC is yet unknown. Post-
translational regulation of both Cx43 levels and function, and the functioning of E-
cadherin might be involved (27). Accordingly, the following model is proposed, as 
showed in Figure 1. This theory is based on the hypothesis that a changed [Ca2+]e 
regulates the GJIC level by changing activities of enzymes involved in intracellular 
signal transduction routes. The observed differences in the effects of a changed [Ca2+]c 
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Table 1: Examples of methods used to study inhibition of gap junctional intercellular 
communication. 
Method 
Metabolic cooperation 
Electric coupling 
Dye transfer 
microinjection in vitro 
microinjection jn vivo 
photo bleaching 
Scrape loading 
Gap junction structure 
electron microscope 
Connexin phosphorylation 
Connexin location 
Connexin mRNA expression 
Cell type 
Mouse epidermal cells/ Swiss 3T3 cells 
Chick embryo hepatocytes/ Chinese hamster 
V79 cells 
Chinese hamster V79 cells 
Human amniotic membrane epithelial cells 
BALB/c 3T3 cells 
Human colon epithelial cell line 
Rat liver 
Human teratocarcinoma cells 
Several cell types 
Chinese hamster V79 cells 
Mouse skin in vivo 
Rat liver in vivo 
Chinese hamster V79 cells 
Mouse primary keratinocytes in vitro 
Rat liver in vivo 
Mouse primary keratinocytes in vitro 
Rat liver in vivo 
Reference 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
60 
62 
on GJIC in two cell types (3PC cells versus CA3/7 cells) may be the result of 
differences in the responsiveness of enzymes involved in signal transduction routes. As 
shown in Figure 1, an increased [Ca2+]e might lead to a higher intracellular calcium 
concentration, which in turn could activate the calcium binding molecule calmodulin 
(CaM). Activated calmodulin could change the gap junction functioning by direct 
binding to connexins, by changing the cAMP concentration and activity of protein 
kinase A (PKA), or by activation of Ca27CaM-dependent protein kinases. These 
protein kinases might phosphorylate connexins directly or indirectly by (in)activation 
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of other protein kinases, leading to a changed phosphorylation level of gap junction 
proteins or (E-cadherin regulating) catenins, and subsequent changed GJIC. 
In order to test this hypothesis, the role of molecules and enzymes involved in 
signal transduction routes in the regulation of GJIC in 3PC cells and in CA3/7 cells 
was studied and described in chapter 3 (regulation by Ca2+, CaM, and Ca27CaM-PK) 
and chapter 4 (regulation by cAMP and PKA). In these chapters the effects of 
modulators of Ca2+- or cAMP-dependent processes on GJIC, Cx43 phosphorylation, 
Cx43 localization and E-cadherin localization are presented. 
The second objective of this thesis is to study differences in susceptibility of cell 
types, representing different stages of tumor formation, for inhibition of GJIC by tumor 
promoters. In chapter 5 the effects of several known tumor promoters, and of several 
agents suspected to have tumor promoting activity, on GJIC are described. Because 
differences in susceptibility of cells for the inhibition of GJIC by tumor promoters may 
be due to different regulation mechanisms, the effects of tumor promoters on Cx43 
phosphorylation, Cx43 localization and E-cadherin localization were studied in primary 
keratinocytes, 3PC cells and in CA3/7 cells. In the chapters 6 and 7, the results of this 
study are presented. 
Because intracellular calcium plays a role in the regulation of GJIC (chapter 3), 
the effects of tumor promoters on the intracellular calcium concentration in both 3PC 
cells and CA3/7 cells were studied and described in chapter 8. In this chapter, also the 
role of extracellular calcium on tumor promoter-induced changes of GJIC and [Ca2+]j 
is described. Finally, the results of the studies described in this thesis are summarized 
and discussed in chapter 9. 
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The following methods were used for the studies described in this thesis: 
Materials 
For the study on the mechanisms controlling GJIC (chapter 3 and 4), the following 
chemicals were used: Lucifer yellow CH (LY), dimethyl sulfoxide (DMSO), l-(5-
iodonaphthalene-1 -sulfonyl)-1 H-hexahydro-1,4-diazepine (ML-7), N-(6-aminohexyl)-5-
chloro-1-naphthalene-sulfonamide (W-7), calmidazolium (CDZ), ionomycin, 
thapsigargin (Tg), forskolin, and 3-isobuthyl-l-methyl-xanthine (IBMX) (obtained from 
Sigma, St.Louis MO, USA). Ethylene glycol-bis(6-amino-ethyl ether) n,n,n',n'-
tetraacetic acid acetoxy-methyl ester (EGTA-AM) (obtained from Molecular Probes, 
Eugene, USA). Rp-Adenosine-3',5'-cyclic-Monophosphate-triethylamine (RpcAMP) 
and Sp-Adenosine-3',5'-cyclic-Monophosphate-triethylamine (SpcAMP) (obtained from 
Research Biochemicals International, Natick MA, USA). LY was dissolved in 0.33 M 
LiCl; ML-7, W-7, CDZ, IBMX, EGTA-AM, ionomycin, Tg and Fura2-AM were 
dissolved in DMSO; and forskolin, EGTA, RpcAMP, and SpcAMP were dissolved in 
water. 
The following agents were used to study the tumor promoter-induced (mechanisms of) 
GJIC inhibition in cell types representing different stages of tumor formation (chapter 
5-9). Benzoyl peroxide (BP), sodium fluoride (NaF), L-ethionone, d-limonene, o-
anisidine and phenobarbital (PB) were obtained from Aldrich Chemie, Bornum, 
Belgium; aroclor 1260 from Interchim, Asnieres, France; l,r-(2,2,2-trichloroethylide-
ne)bis[4-chlorobenzene] (DDT)) from Cluzeau info lab, Sainte-Foy-la-Grande, France; 
and clofibrate, and 12-o-tetradecanoyl-phorbol-13-acetate (TPA) from Sigma, St.Louis 
MO, USA. The used agents are considered to be tumor promoters due to their non-
mutagenicity in S. typhimurium and their carcinogenic effects in in vivo experiments 
(see chapter 5). 
DDT, o-anisidine and TPA were dissolved in dimethyl sulfoxide (DMSO, Sigma); 
clofibrate and d-limonene in ethanol (Sigma); NaF and PB in distilled water; L-
ethionone in 1 M HC1; and aroclor 1260 in acetone (Sigma). 
Cell lines and cell culture. 
The cell lines used in this study (3PC and CA3/7) represent an early and a late stage 
of mouse skin carcinogenesis and are described by Klann et al.(1989). In brief: the 3PC 
cell line was obtained after in vitro initiation with DMBA and selection for calcium 
resistance. These cells are thought to be initiated cells because of the fact that these 
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cells do not differentiate in response to high (1.20 mM) extracellular calcium 
conditions (2). The CA3/7 cell line was obtained from a carcinoma 16 weeks after 
completion of the DMBA/TPA regimen. The characteristics of these cell lines and the 
cell culture procedures are described elsewhere (1, 3). The cells were cultured in low 
calcium medium (0.05 mM). For experiments under high extracellular calcium 
conditions, cells were cultured for 24 hours in medium containing 1.20 mM Ca2+, after 
which experiments were performed in the same medium. 
HepG2 cells were cultured in FlO-medium supplemented with 10% FCS (GIBCO 
Europe BV, Breda, The Netherlands) under the same conditions as the 3PC cell line. 
Primary keratinocytes from CD-I mice were isolated and cultured as described by 
Klann et all. (1). 
Gap junctional intercellular communication (GJIC). 
GJIC was measured by the fluorescent dye transfer method, using microinjection of 
Lucifer Yellow CH and counting the number of fluorescent cells 10 minutes after 
injection. After determination of the control level, the cells in the same petri-dish were 
subsequently exposed to the test agent (t=0) and GJIC was determined at different 
time-points after t=0. At every time-point 20 cells were injected and every experiment 
was performed at least in duplicate (variation < 7%). Experiments under conditions 
without Ca2+e were performed by washing a confluent cell layer with Ca2+-free PBS and 
subsequent exposure of the cells to the selected agents in PBS. GJIC under high 
extracellular (Ca2+e) calcium conditions was determined by culturing the cells for 24 
hr in medium containing 1.2 mM calcium. Then the control GJIC was determined, after 
which the cells were exposed to a test agent under the same Ca2+e conditions. The 
control GJIC levels at low respectively high extracellular calcium conditions were for 
3PC cells 31.9 and 34.8, and for CA3/7 cells 2.5 and 34.6 (variation <10%). The 
control GJIC level of primary keratinocytes and HepG2 cells under low extracellular 
calcium conditions were 18 and 3 respectively. Results are expressed as the percentage 
remaining GJIC, or as the percentage of GJIC inhibition compared to GJIC at t=0 
(100%). Agents that did not show direct inhibition of GJIC in the cell line 3PC 
(chapter 5) were further tested in two ways: A) after a preincubation of the agent with 
an aroclor 1254 induced liver homogenate S9 and the appropriate co-factors for 30 
minutes (64), cells were exposed to this mixture and GJIC was determined and B) in 
the cell line HepG2 to determine the possible role of metabolic activation of these 
agents. At least 40 HepG2 cells were injected and the experiments were performed in 
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duplicate. Cell viability was tested by Trypan Blue exclusion directly after 
determination of GJIC and was never below 95%. In the concentrations used, solvents 
had no effect on GJIC. 
B 
Figure 1: Examples of GJIC in a cell line with a high GJIC level (A) or low GJIC level (B). The cell 
which is microinjected with the fluorescent dye, is marked (*). 
Western blotting. 
Directly after GJIC measurements, whole cell protein extract was obtained from the 
treated cells by cell lysis with a sample buffer (62.5 mM Tris-HCl, pH 6.8, 0.5% 
SDS). Protein quantification and Western blotting of connexin43 (Cx43) were 
performed as described by Mesnil et al.(4). Analysis of E-cadherin was done using a 
10% polyacrylamide gel and a rat anti E-cadherin primary antibody (Sigma, St Louis, 
MO). For the determination of both the Cx43 and E-cadherin protein, the ECL-
technique of Amersham (Little Chalfont, England) was used. The efficiency of gel 
electrophoresis and blotting were checked by Coommassie Blue and Ponceau red 
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staining, respectively. The percentage of phosphorylated Cx43 was determined by 
scanning the autoradiograms from the Western analysis on the Quantity One system 
from pdi, Huntington Station, NY. The results are expressed as the percentage 
phosphorylated CX43 relative to the percentage phosphorylated Cx43 under control 
conditions (which were under low Ca2+e conditions 40.6% and 27.9%, and under high 
Ca2+e conditions 59.5% and 56.3% for 3PC cells and CA3/7 cells respectively). 
Immunocytofluorescence. 
For E-cadherin and Cx43 immunostaining, cells were handled as described by Mesnil 
et al. (4). For E-cadherin staining, the same antibody was used as for Western blotting 
technique, for Cx43 the mouse derived antibody was purchased from TEBU 
(Nottingham, UK). Biotinylated second antibodies and FITC-conjugated streptavidin 
from Sigma (St Louis, MO, USA) were used. The level of immunostaining was 
determined as 1 of 5 grades of staining, ranging from high to undetectable (+++, ++, 
+, +/- and -). 
Intracellular calcium measurements. 
The intracellular calcium concentration was determined by loading the cells with 2,67 
uM Fura2-AM (Sigma, St.Louis MO, USA) for 30 minutes at room temperature. The 
intracellular calcium concentration was determined using the Cue-2 dual wavelength 
calcium measurement system (PAES bv, Zoeterwoude, The Netherlands) and by 
measuring the fluorescence ratio by dividing the fluorescence values at wavelengths 
340/380. These ratios were transformed into intracellular calcium concentrations by 
using the formula 
[Ca2+]i = Kd * ((R-Rmin)/(Rmax-R)) * (Sf/Sb) 
in which Kd is the dissociation constant of Fura-2 and Ca2+ (224 nM); R is the 
measured ratio; Rmax is the maximum ratio after addition of KCN, ionomycin and 
CaCl2 to final concentrations of 4 mM, 10 uM and 1.2 mM, respectively; Rmin is the 
minimum ratio after addition of 10 mM EGTA; and Sf and Sb are the fluorescence 
values at 380 nm at Rmin and Rmax calcium concentrations, respectively (5). Rmax 
and Rmin were determined directly after the experiment. The given intracellular 
calcium concentrations are the mean of at least 2 experiments, in which the influence 
of calcium modulating agents on the intracellular calcium concentrations of 10 
individual cells was determined. 
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Statistics. 
For each concentration, GJIC or Ca2* at different time points were compared to the 
values for the control using ANOVA with a block effect to allow for systematic 
differences between petri-dishes. The effect of time and agent were investigated using 
the REsidual Maximum Likelihood method (REML) of the Genstat 5 package (Genstat, 
Rothamsted, UK). This method is similar to ANOVA, however it allows for the fact 
that there are different numbers of cells for each combination of agent and time-point, 
causing the datasets to be unbalanced in the statistical sense. The variation within one 
experiment, and between the two duplicate experiments were always below 15% for 
both GJIC and intracellular calcium experiments. 
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Differences in the calcium-mediated regulation 
of gap junctional intercellular communication 
between a cell line consisting of initiated 
cells and a carcinoma-derived cell line. 
This chapter is based on the paper: 
L.A.M.Jansen, T.de Vrije and W.M.F.Jongen (1996) Differences in the calcium-mediated regulation of gap 
junctional intercellular communication between a cell line consisting of initiated cells and a carcinoma-
derived cell line. Carcinogenesis, in press. 
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Abstract 
Differences in calcium-mediated regulation of gap junctional intercellular 
communication (GJIC) between a cell line consisting of mouse epidermal initiated cells 
(3PC) and a mouse epidermal carcinoma-derived cell line (CA3/7) were studied. Under 
low extracellular calcium (Ca2+e) conditions (0.05 mM) CA3/7 cells showed a low level 
of GJIC compared to 3PC cells. High Ca2+e (1.20 mM) raised GJIC between CA3/7 
cells to the GJIC level of 3PC cells, which in turn remained unchanged under these 
conditions. Raising the free intracellular calcium concentration (Ca2+j), using a calcium 
ionophore (ionomycin) or the Ca2+-ATPase inhibitor thapsigargin under low Ca2+e 
conditions, did not affect the GJIC level between 3PC cells, and increased GJIC 
between CA3/7 cells. Intracellular calcium chelation in 3PC cells under low Ca2+e 
conditions by ethylene glycol-bis(8-amino-efhyl ether) n,n,n',n'-tetra-acetic acid 
acetoxy-methyl ester (EGTA-AM) decreased GJIC in this cell line. High Ca2+e 
conditions protected both cell lines from a decreased GJIC by EGTA-AM exposure. 
Inhibition of calmodulin (CaM) by calmidazolium (CDZ) or N-(6-aminohexyl)-5-
chloro-1-naphthalene-sulfonamide (W-7) under low Ca2+e conditions, inhibited GJIC 
in 3PC cells and increased GJIC in CA3/7 cells. Inhibition of Ca27CaM-dependent 
protein kinase (Ca27CaM-PK) by l-(5-iodonaphthalene-l-sulfonyl)-lH-hexahydro-l,4-
diazepine (ML-7) decreased GJIC in both cell lines. Western analysis showed that 
Cx43 was more phosphorylated in both cell lines in concurrence with different effects 
on the GJIC level. Under conditions in which GJIC was inhibited, a decreased 
immunostaining of Cx43 on the plasma membrane was found. The level of 
immunostaining of the cell adhesion molecule E-cadherin on the plasma membranes 
of both cell types remained unchanged under conditions in which GJIC was changed 
by modulaters of [Ca2+]j, CaM activity, or the Ca27CaM-PK activity. These results 
indicate that differences exist between 3PC cells and CA3/7 cells in the GJIC 
regulation by intracellular calcium and calmodulin. 
Introduction 
Intercellular communication through gap junctions (GJIC) is involved in many 
biological processes like metabolic cooperation (1), cell proliferation (2,3) and cell 
differentiation (4). It has been hypothesized that in the multistep process of tumor 
formation, a decreased gap junctional intercellular communication of genetically altered 
(initiated) cells could favorize their clonal expansion (2,5,6). 
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Gap junctions are intercellular channels, permitting small metabolites, ions and second 
messengers to pass to neighbouring cells. The channels are made of juxtaposed 
connexons crossing the membrane of two adjacent cells. Each connexon is formed by 
six protein subunits called connexins (7,8). How the functioning of connexons is 
regulated is still largely unknown but phosphorylation of the connexins could play an 
essential role. Indeed changes in phosphorylation levels of connexins have been 
reported to correlate with reduced (9,10) or stimulated GJIC (11). These changes can 
be achieved by (de)activation of protein kinases, however the mechanisms controlling 
this way of regulation are unknown. Changes in second messenger concentrations like 
intracellular calcium or cAMP could (de)activate GJIC modulating enzymes. 
Alterations in these parameters or the responses of enzymes to second messengers 
could play a part in the presumed role of altered GJIC in the process of tumor 
formation. 
Earlier research showed that during the process of tumor formation GJIC declines in 
human keratinocyte cell lines (12), and in mouse epidermal cell lines (13). Elevated 
extracellular calcium concentrations were shown to restore GJIC of papilloma- and 
carcinoma-derived (CA3/7 cells) mouse epidermal cell lines to levels comparable with 
primary keratinocytes, while the high GJIC level of a cell line consisting of initiated 
mouse epidermal cells (3PC) remained unchanged after increasing the extracellular 
calcium concentration ([Ca2+]e) (14). This suggests that differences exist in the 
extracellular calcium regulated control of GJIC between the 3PC cell line and the 
CA3/7 cell line. An increased [Ca2+]e might lead to a higher intracellular calcium 
concentration, which in turn could activate the calcium binding molecule calmodulin 
(CaM) (Fig 1). Activated calmodulin could change the gap junction functioning by 
direct binding to connexins (15,16), or by activation of Ca27CaM-dependent protein 
kinases. These protein kinases might phosphorylate connexins directly (17) or indirectly 
by (in)activation of other protein kinases, leading to a changed phosphorylation level 
of gap junction proteins and a changed GJIC. 
To investigate possible differences between initiated (3PC) cells compared to a 
carcinoma derived cell line (CA3/7) in the mechanisms controlling GJIC, we studied 
the role of calcium-mediated alterations in the regulation of GJIC in these cell lines. 
Because in mouse keratinocytes GJIC was shown to be also regulated by the cell 
adhesion molecule E-cadherin (14), we also studied the role of calcium mediated 
processes on the amount and location of E-cadherin. 
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Figure 1: (Working) Hypothesis for the regulation of gap junctional intercellular communication by the 
calcium signal transduction route. For explanation see introduction. The agents used in this study with a 
positive (+) or negative (-) effect on a certain concentration or activity are given. Ca2+C, Ca2*~ extracellular 
respectively intracellular calcium; CaM= calmodulin; Ca27CaM-PK 11= Ca27calmodulin dependent protein 
kinase II; Cx43= connexin43. Small typed agents are used to stimulate (+) or inhibit (-) Ca27CaM-dependent 
processes or concentrations. 
Results 
Several calcium and calmodulin modulating agents were used to study the calcium 
dependent regulation of gap junctional intercellular communication (GJIC) in a cell line 
of initiated mouse epidermal cells (3PC) and in a mouse epidermal carcinoma-derived 
cell line (CA3/7). 
Under low Ca2+e conditions (0.05 mM), the 3PC cell line has a much higher GJIC level 
than the CA3/7 cell line (Fig 2A). A high [Ca2+]e (1.20 mM) did not affect the GJIC 
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level in 3PC cells, whereas the GJIC level of CA3/7 cells was increased to levels 
comparable to 3PC cells within 24 hours. At low Ca2+e conditions, the basal [Ca2+]; was 
not significantly different in the 3PC cells compared to the CA3/7 cells (Fig 2B) and 
ammounted to approximately 110 nM. A change in [Ca2+]e caused in 3PC cells a first 
peak in the [Ca2+]i up to 500 nM after 5 minutes. The [Ca2+]j returned to the basal level 
after 7 minutes. A second [Ca2+]j peak (up to 250 nM) was observed at 90 minutes 
after the changed [Ca2+]c, and the [Ca2+]i decreased again to the control level within 24 
hours. The Ca2+e-induced changes in [Ca2+]j, as well as the [Ca2+]j after 24 hours high 
Ca2+e conditions were comparable in 3PC cells compared to CA3/7 cells. 
To discriminate between an effect of Ca2+e or Ca2* on GJIC, the [Ca2+]; was 
elevated under low Ca2+e conditions using the calcium ionophore ionomycin (21), or 
to the Ca2+-ATPase inhibitor thapsigargin (Tg, 22). During the first 90 minutes, the 
effect of 10 |JM ionomycin and 5 pM Tg on [Ca2+]j in 3PC cells was comparable to 
the effect of the high Ca2+e condition on [Ca2+]j (Fig 3A). Both agents induced a first 
peak of [Ca2+]i (up to 370 nM) after which [Ca2+]j returned to the basal level. In 
ionomycin exposed 3PC cells [Ca2+]j increased then up to 200 nM after 90 minutes, 
whereas in Tg exposed cells [Ca2+]; remained constant. 
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Figure 2: The effect of 1.20 mM Ca2+e on GJIC (A) and on [Ca2t], (B) in 3PC cells and in CA3/7 cells. At 
t=0 min [Ca2*]e was increased and the number of communicating cells (A) and the [Ca2+]j were followed in 
time. Open symbols: 3PC cells, closed symbols: CA3/7 cells. 
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B 
Figure 3: The effect of Ca2* modulators on [Ca2*]; (A) and on GJIC (B). At t=0 min. a calcium modulator 
was added to the medium and the [Ca2+]; (A) or the percentage GJIC compared to t=0 (B) were determined. 
Symbols represent: A 10 uM ionomycin; v 5 uM thapsigargin; • 100 uM EGTA-AM; open symbols 3PC 
cells, and closed symbols CA3/7 cells. 
In CA3/7 cells however, Tg only slightly increased [Ca2+]; (150 nM), and ionomycin 
raised the [Ca2*], after 90 minutes to the same level as the high Ca2+e condition did, 
however without a first transient peak of [Ca2+]j at 5-10 minutes. Both ionomycin and 
Tg had no effect on GJIC in 3PC cells, whereas they increased GJIC in the CA3/7 cell 
line (Figure 3B). Potentially, a decreased [Ca2+]; could inhibit GJIC in the 3PC cells 
(which have a high GJIC level under low Ca2+e conditions). Therefore both cell types 
were exposed to the intracellular calcium chelator EGTA-AM (23). As shown in 
Fig.3A, exposure to 100 |JM EGTA-AM decreased [Ca2+]i only transiently in 3PC cells 
under low Ca2+e conditions. In these cells however, the GJIC level was decreased 
strongly (Fig 3B). Under high Ca2+e conditions in both cell lines, both GJIC and [Ca2+]j 
levels were not significantly changed by EGTA-AM (data not shown). 
The changes in [Ca2^ could exert their effect on GJIC by changing the activity 
of calmodulin (CaM) and/or a Ca27CaM-dependent protein kinase (Ca27CaM-PK). To 
establish whether differences in GJIC regulation exist between 3PC cells and CA3/7 
cells on this level of regulation, the effect of the CaM inhibitors W7 (24) and CDZ 
(25), and of an inhibitor of Ca27CaM-PK (ML-7, 26) on GJIC were studied. In the cell 
line 3PC, 20 uM W7 decreased GJIC by 50% while in the CA3/7 cell line the level 
of GJIC was doubled in the same time (Figure 4A). 
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Figure 4: The effect of CaM inhibitors on GJIC (A) and [Ca2*]; (B). At t=0 min. a calmodulin inhibitor was 
added to the medium and GJIC (A) or [Ca2*], (B) were determined. Symbols represent: A 5 uM CDZ; v 
10 uM CDZ; • 1 uM CDZ; O 20 uM W7; open symbols 3PC cells, and closed symbols CA3/7 cells. 
CDZ had the same effect as W7 on GJIC in 3PC cells and CA3/7 cells, but it was 
more effective at lower concentrations. The increase of the GJIC level in CA3/7 cells 
was faster than the high Ca2+e-induced increase of the GJIC level. Additionally the 
effects of these agents on [Ca2+]j levels were studied. Both agents increased [Ca2+]j 
under low Ca2+e conditions, although the W7-induced increase of [Ca2+]j was only 
temporary in 3PC cells (Fig 4B). Whereas 5 uM CDZ increased [Ca2+]; up to 260 nM 
in CA3/7 cells after 60 minutes of exposure, 10 |aM CDZ had no effect on [Ca2+]; in 
CA3/7 cells under these conditions. The Ca27CaM-PK inhibitor ML-7 inhibited GJIC 
in both cell lines in concurrence with a slight increase of the [Ca2+]j level (Fig 5). 
Figure 5: The effect of ML-7 on GJIC and 
[Ca2+]i. ML-7 was added to the medium at t=0 
min. and GJIC or [Ca2*]; were determined. 
Symbols represent: O 1.0 uM ML-7-GJIC; A 10 
uM ML-7-GJIC; D 10 uM ML-7-Ca2+i;open 
symbols 3PC cells, and closed symbols CA3/7 
cells. 
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Calcium 
Ionomycin (10 uM) 
EGTA-AM (100 uM) 
CDZ (5 uM) 
ML-7 (10 uM) 
LOW 
1.63 
1.75 
1.24 
1.79 
3PC 
HIGH 
nt 
0.92 
1.06 
1.32 
LOW 
2.06 
1.11 
1.44 
1.30 
CA3/7 
HIGH 
nt 
1.61 
1.29 
1.52 
Table 1: The ratio of the percentage phosphorylated Cx43 in exposed cells and the percentage 
phosphorylated Cx43 under control conditions. The [Ca2+]e was 0.05 mM and 1.20 mM for low and high 
calcium medium respectively. The control % of phosphorylated Cx43 were under low Ca2+C conditions 
40.6% and 27.9%, and under high Ca2+0 conditions 59.5% and 56.3% for 3PC cells and CA3/7 cells 
respectively. nt= not tested. 
B 
c i e cd m e cd ni 
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Figure 6: Western blot analysis of connexin43 in CA3/7 cells (A and C) and in 3PC cells (B and D) after 
90 minutes of exposure under low (A and B) and high (C and D) extracellular calcium conditions. c=control 
(untreated) cells, i= 10 uM ionomycin; e= 100 uM EGTA-AM; cd= 5uM CDZ; and m= 10 uM ML-7. 
In both cell lines, the effects of ML-7 on both GJIC and [Ca2+]; were the same under high 
Ca2+e conditions as under low Ca2+e conditions (data not shown). Because the functionality 
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AGENT 
(MM) 
Control 
Control 
Ionomycin 
(10) 
EGTA-AM 
(100) 
EGTA-AM 
(100) 
CDZ (5) 
CDZ (5) 
ML-7 (10) 
ML-7 (10) 
Calcium 
(mM) 
0.05 
1.20 
0.05 
0.05 
1.20 
0.05 
1.20 
0.05 
1.20 
GJIC1 
100% 
= 
= 
1 
= 
1 
= 
1 
1 
3PC 
Cx432 
phosphorylation 
control 
control 
t 
T • 
= 
T 
t 
T 
T 
Cx43 
location3 
+++ 
+++ 
= 
I I 
1 
1 
1 
u 
l+c 
GJIC1 
100% 
T 
T 
= 
= 
t 
= 
1 
1 
CA3/7 
Cx432 
phosphorylation 
control 
control 
T 
T 
= 
T 
T 
T 
T 
Cx43 
location3 
++ 
+++ 
= 
= 
1 
= 
1 
I I 
1 
Table 2: Effect of several agents on GJIC, Cx43-phosphorylation and -immunstaining, and on E-cadherin 
immunostaining in the cell lines 3PC and CA3/7. 1: Compared to control-L (= 100%) Symbols =,T,I 
represent an unchanged, an increased or a decreased GJIC respectively; 2: Compared to the control under 
the same Ca++ conditions, Symbols =,t, l represent an unchanged, an increased or a decreased Cx43-
phosphorylation respectively; 3: Compared to the control under the same Ca+* conditions, Symbols =, I, I I , 
+c represent an unchanged, a decreased, a strongly decreased, or an increased cytosolic intensity of 
immunostaining respectively. 
of gap junctions may be regulated by phosphorylation of the gap junction proteins, the 
effects of the used calcium/calmodulin modulators on Cx43 phosphorylation were 
studied (Fig.6 and Table 1). 
Under low Ca2+e conditions Cx43 is more phosphorylated in the 3PC cells (41%) 
compared to the CA3/7 cells (28%), under high Ca2+e conditions the level of Cx43 
phosphorylation in both cell lines (respectively 60% and 56%) is comparable (Fig.6). 
Cx43 phosphorylation was increased in both cell lines under low Ca2+e conditions by 
all tested agents (as shown by an increased intensity of the Px-band in concurrence with 
a decreased intensity of the NP-band as compared with the control sample). Under high 
Ca2+e conditions, both CDZ and ML-7 increased Cx43 phosphorylation in both cell 
lines, whereas EGTA-AM had no effect on the level of Cx43 phosphorylation in both 
CA3/7 and 3PC cells. The effects of the used agents on Cx43 phosphorylation in both 
cell lines are summerized in Tables 1 and 2. 
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Figure 7: Immunostaining of Cx43 in 3PC cells (A) and in CA3/7 cells (B). Representive pictures are shown 
of cells under low (A1-A4, Bl, B2) or high (B3, B4) Ca2+C conditions; control staining (Al, Bl , B3); a 
decreased staining (I in Table 2, pictures A2, B4); a strongly decreased staining ( i i , A3, B2), and a 
decreased staining on the membrane with cytosolic staining (4-+c, A4). Narrow arrow heads mark examples 
of staining on the membranes, broad arrow head marks an example of cytosolic immunostaining (A4). In 
addition to the specific staining (examples marked by arrow heads), non-specific autofluorescence of the 
cells, due to the long exposure time of the films, can be seen. Bar = 25 um in both series A and B. 
Besides a change of the phosphorylation of Cx43, the level of GJIC may be changed 
by a change in the localization of Cx43. Table 2 and Figure 7 show that under low 
Ca2+e conditions, the intensity of Cx43 immunostaining on the membranes of CA3/7 
cells was lower than in 3PC cells. Under high Ca2+e conditions, the 
immunofluorescence intensity was increased in CA3/7 cells up to a level comparable 
to 3PC cells. The Cx43-linked immunostaining intensity in 3PC cells was not changed 
by an increased [Ca2+]e. In both cell lines under low Ca2+e conditions, ionomycin 
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• E-cadhcrin 
exposure did not affect the Cx43-linked immunofluorescence intensity. The EGTA-
AM-induced decrease in Cx43-linked immunostaining in 3PC cells was higher under 
low Ca2+e conditions compared to high Ca2+e conditions. In CA3/7 cells EGTA-AM 
only decreased Cx43 immunostaining under high Ca2+e conditions. CDZ decreased 
Cx43 immunostaining in 3PC cells 
under both Ca2+e conditions to the same 
extent. In CA3/7 cells only under high 
Ca2* conditions CDZ decreased Cx43 A 
immunostaining. Under both Ca2+e 
conditions, ML-7 decreased Cx43 
immunostaining in both cell types. 
Because in mouse keratinocytes 
GJIC was shown to be also regulated 
by the cell adhesion molecule E-
cadherin (14), we studied the effects of
 A 
mediators of Ca2+-regulated processes 
on the amount and location of E-
cadherin. Neither an increased [Ca2+]e, 
nor treatment of both cell types with 
ionomycin, CDZ, or ML-7, changed the 
amount of E-cadherin in both cell types 
as determined by Western analysis (as B 
shown for CA3/7 cells in Fig 8A). 
Changing [Ca2+]e from 0.05 mM to 1.2 
mM s t rong ly inc reased the 
immunostaining of E-cadherinon the 
cel l -ce l l con t ac t a reas in Figure 8: Western analysis (A) and 
immunostaining (B) of E-cadherin in 3PC cells 
and CA3/7 cells. A: The amount of E-cadherin 
remains unchanged after treatment of 3PC 
cells with modulators of Ca2+ dependent processes. Symbols as in Fig.6. This blot is representive for the 
effect of the used agents on both cell lines under both Ca2+C conditions. B: E-cadherin immunostaining of 
3PC (A) and CA3/7 (B) cells under low (1) and high (2) Ca2+C conditions. In addition to the specific staining 
on the membranes (examples marked by arrow heads), non-specific autofluorescence of the cells, due to the 
long exposure time of the films, can be seen. Bar = 25 um. 
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both cell lines (Table 2 & Figure 8B). The intensity of E-cadherin-linked 
immunofluorescence was not changed by ionomycin, CDZ, EGTA-AM or ML-7 under 
both low and high Ca2+e conditions (Table 2). 
Discussion 
In this study we demonstrate, that a difference in the regulation of GJIC by calcium-
and calmodulin-dependent mechanisms between a cell line of initiated mouse 
keratinocytes and a carcinoma derived cell line exists. Furthermore the data show that 
changes in GJIC induced by modulators of the calcium signal transduction route, are 
not associated with concurrent changes in Cx43 phosphorylation levels. Under 
conditions in which GJIC was inhibited, a decreased level of immunostaining of Cx43 
on the membranes was found. The level of immunostaining of the cell adhesion 
molecule E-cadherin was, under the experimental conditions used in this study, not 
changed by modulators of Ca2* or CaM. 
High extracellular calcium conditions did not affect the high GJIC level in 3PC 
cells. In the mouse skin carcinoma derived cell line however, a shift to 1.20 mM Ca2+e 
raised the level of GJIC to that of the 3PC cell line. These results confirm earlier 
findings (14). Several other groups have reported different effects of Ca2+e on GJIC. 
In primary keratinocytes 2 mM Ca2+e induced a decreased GJIC (27), whereas 
decreased extracellular calcium conditions (1.8 mM to 0.05 mM) inhibited GJIC in 
human keratinocytes (12). In this study no differences were found between the effects 
of high extracellular calcium on [Ca+]j in 3PC cells and in CA3/7 cells. This suggests 
that the regulation of calcium transport across the membranes is functioning with a 
comparable efficiency in both cell lines. These results also suggest that the [Ca2+]j in 
3PC cells is optimal for a high GJIC level, whereas in CA3/7 cells a higher [Ca2+]j is 
needed to induce a high GJIC level. The effect of 1.20 mM Ca2+e on [Ca2+]; in both cell 
lines is the same as reported by others for neoplastic keratinocytes (28,29). Kruszewski 
et al. found that [Ca2+]j in normal kerationocytes remained at a three times higher level 
after 22 hours of high [Ca2+]e compared to the level at low Ca2+e conditions (29). The 
[Ca2+]j of the 3PC cell line however returned also to the basal level. This apparent 
difference may be a result of the selection procedure of this cell line, i.e. treatment 
with a initiating agents followed by selection under high extracellular calcium 
conditions. 
Both the calcium ionophore ionomycin and the Ca2+-ATPase inhibitor 
thapsigargin increased GJIC between CA3/7 cells. This ionomycin-induced rise in GJIC 
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level was comparable with the high Ca2+e-mitiated GJIC rise after 90 minutes. 
Therefore, the effect of high Ca2+e on GJIC in CA3/7 cells could be the result of an 
increased [Ca2+]j. The GJIC level in 3PC cells remained unchanged after exposure of 
the cells to ionomycin or Tg. These results suggest that changes can exist in calcium 
regulated GJIC in cells representing different stages in the process of tumor formation. 
The kinetics of the ionomycin-induced raise of [Ca2+]; in 3PC cells is comparable to 
the high Ca2+e-mduced [Ca2+]j rise in these cells. In CA3/7 cells however, ionomycin 
did not induced a first trancient [Ca2+]j increase. Contrary to these results, Crow et al. 
(1994) found a decreased GJIC between bovine lens cell cultures when Ca2+j was 
increased by ionophores under high Ca2+e conditions (30), and the calcium ionophore 
A23187 caused an inhibition of GJIC in Chironomus salivary gland cells under high 
Ca2+e conditions (31). Furthermore an increased [Ca2+]; reduced GJIC in hepatoma cells 
cultured under high Ca2+e conditions (32). These apparent discrepancies could be the 
result of the type of cells used. 
Because many calcium dependent processes are regulated via the calcium 
binding molecule calmodulin (CaM), and CaM plays a role in the regulation of GJIC 
possibly by binding to connexins (15,16) or by activation of connexin-phosphorylation 
protein kinases (Fig.l), the effect of CaM inhibitors on GJIC was studied in both cell 
lines. Interestingly, the two CaM inhibitors had opposite effects in 3PC cells and 
CA3/7 cells. Whereas under low Ca2+e conditions GJIC was decreased in 3PC cells, 
GJIC was increased in CA3/7 cells by CaM inhibition. Under high Ca2+e conditions the 
GJIC level was not changed by CaM inhibitors in both cell types. Exposure under high 
Ca2+e conditions to several CaM inhibitors did not decreased GJIC in different cell 
types (33-35). This is concistent with our results with both cell lines. However, in 
Beetle epidermis (36) the GJIC level was decreased by exposure of the cells to CaM 
inhibitors under high Ca2+e conditions. The reason for this discrepancy is unknown. The 
results under low Ca2+e conditions suggest that changes in CaM-dependent regulation 
of GJIC may be associated with the process of tumor formation. Because the CaM-
induced effect on GJIC is different in both cell lines under low Ca2+e conditions, this 
suggests that direct binding of CaM to Cx43 alone is not enough to be a mechanism 
by which CaM regulates the GJIC level. 
Exposure of both cell lines to CDZ or W-7 led to a (transient) [Ca2+]; increase 
(Fig 4B). A transient increased [Ca2+]j was also reported for MDCK cells exposed to 
the CaM inhibitor trifluoperazine (37). This may be due to inhibition of the CaM-
dependent plasma membrane calcium pump (25, 38). In this study we showed that in 
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3PC cells the [Ca2+]i was sufficiently high to preserve a high GJIC level, and that an 
increased [Ca2+]j did not affect this GJIC level. The results obtained with CaM 
inhibitors in both cell lines suggest that the effects of CaM on GJIC are more 
important than the stimulating effects on [Ca2+]j. 
Because CaM may exert its effect on GJIC by activation of Ca+7CaM-dependent 
protein kinase (Ca27CaM-PK), and because Saez et al.(1990) showed that activated 
Ca27CaM-PK resulted in an increased Cx32 phosphorylation, we studied the effects 
of an inhibitor of Ca27CaM-PK (ML-7) on GJIC in both cell lines. GJIC was 
decreased in both cell lines by treatment of the cells with ML-7 under low and high 
Ca2+e conditions. This suggests that the differences found between 3PC cells and CA3/7 
cells in the regulation of GJIC are not due to differences in the regulation of GJIC by 
Ca27CaM-PK. In concurrence with the ML-7-induced GJIC inhibition Cx43 was 
hyperphosphorylated in both cell lines under both Ca2+e conditions, suggesting no direct 
phosphorylation of Cx43 by Ca27CaM-PK. In addition to the GJIC inhibition by ML-7, 
[Ca2+]i was increased. How ML-7 may affect the [Ca2+]; is however unknown. 
Ca2+r or CaM-modulating agents could affect GJIC by activation of Ca27CaM-
dependent protein kinases and subsequent (in)direct connexin phosphorylation (Fig.l). 
Here we show that exposure of both cell types to ionomycin or EGTA-AM results in 
an increased Cx43 phosphorylation. Crow et al.(1994) showed a decreased GJIC in 
concurrence with a decreased amount of phosphorylated Cx43 in bovine lens cells 
exposed to calcium ionophores (30). However, in accordance with this study, more 
phosphate groups per Cx43 were found. Experiments with CDZ and ML-7 showed that 
CaM-dependent enzymes are involved in the phosphorylation level of Cx43 (Fig 6). 
However, no clear relationship can be found between Cx43-phosphorylation and effects 
on GJIC (Table 1). Analysis of the specific amino acid residues of Cx43 
phosphorylated by exposure of the cells to Ca2+- or CaM-modulating agents might give 
more information about the question whether such relationship exists. 
The intensity of Cx43-linked immunostaining on the cell membrane was 
decreased by EGTA-AM, CDZ or ML-7. All treatments of both cell types with 
modulators of the suppost calcium signal transduction pathway which inhibited GJIC, 
at the same time affected Cx43 immunostaining levels on the membrane. Because the 
amount of Cx43 remained unchanged (as determined by Western analysis), this 
suggests that the used agents cause a dispersion of Cx43 over the membrane, after 
which the immunofluorescence intensity decreases below detection limits. 
The cell adhesion molecule E-cadherin was shown to regulate GJIC in mouse 
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keratinocytes (14). The functioning of E-cadherin is regulated by adhesion of catenins 
to E-cadherin (39,40), and appears to be a calcium and phosphorylation related process 
(41,42). To determine whether E-cadherin regulation is involved in the differences 
between 3PC cells and CA3/7 cells in the regulation of GJIC, we studied the effects 
of ionomycin, CZD, and ML-7 on the amount and location (Fig. 7) of E-cadherin 
protein in both cell lines. None of the tested modulators of the signal transduction route 
had any effect on the E-cadherin-linked immunostaining on the membranes of the cells, 
suggesting that the location of E-cadherin is not directly regulated by Ca2+rdependent 
enzymes. The fact that an increased [Ca2+]e increased the intensity of the E-cadherin 
immunostaining on the membrane in both cell types, while the amount of E-cadherin 
remained unchanged, suggests that the E-cadherin molecule underwent a 
conformational change, or that it became more clustered. 
This study shows that differences exist between the 3PC cells and the CA3/7 
cells in the regulation of GJIC by Ca2+e These differences are not due to differences 
between the two cell types in the transmembrane transport efficiency of calcium; the 
regulation of GJIC by Ca2+/CaM-PK, nor by the Ca2+7CaM-regulated E-cadherin 
location. However, differences between the two cell types were found 1) in the 
requirement for a peak of Ca2+; to establish full GJIC; and 2) in the CaM-dependent 
regulation of GJIC. The results of this study suggest that not only the binding of CaM 
to Cx43 is the mechanism by which CaM regulates GJIC. CaM inhibition has 
differential effects on the GJIC level in both cell lines. This could be due to the 
involvement of several different CaM-dependent enzymes in the regulation of GJIC. 
One possible candidate may be Ca27CaM dependent phosphodiesterase, an enzyme 
which brakes down cAMP (43,44), because of the role of cAMP-stimulated protein 
kinase A in the regulation of GJIC (45,46). 
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Cyclic amp-mediated control of gap junctional 
intercellular communication is differentially regulated in 
initiated and carcinoma cells 
This chapter is based on the paper: 
L.A.M.Jansen, T.de Vrije, C.van de Berg, and W.M.F.Jongen (1996) Cyclic AMP-mediated control of 
gap junctional intercellular communication in an initiated- and carcinoma-derived cell line. Submitted to 
Carcinogenesis. 
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Abstract 
cAMP-mediated regulation of gap junctional intercellular communication (GJIC) 
was studied in a cell line consisting of initiated cells (3PC) and a carcinoma derived 
cell line (CA3/7). Under low (0.05 mM) extracellular calcium (Ca2+e) conditions, 
forskolin and a specific protein kinase A (PKA) activator increased the low GJIC 
level of CA3/7 cells, but not the high GJIC level of 3PC cells. Furthermore GJIC 
was reduced by PKA inhibition in 3PC cells under low, but not under high Ca2+e 
conditions. Both PKA inhibition and PKA stimulation could not change the GJIC 
level in CA3/7 cells under high Ca2+e conditions. Analysis of the level of 
connexin43 (Cx43) phosphorylation showed that no direct relationship exists 
between PKA-modulator-induced change in the percentage of phosphorylated Cx43 
and the level of GJIC. Exposure of CA3/7 cells under low Ca2+e conditions to 
(in)direct PKA activators raised the GJIC level in concurrence with an increased 
Cx43 immunostaining on the plasma membrane. Under high Ca2+e conditions, both 
the high GJIC level and the Cx43 immunostaining remained unchanged. The 
amount and localization of the cell adhesion molecule E-cadherin were not changed 
by treatment of the cells with cAMP/PKA modulators. Finally, no relationship 
between the cAMP/PKA-induced change in intracellular calcium concentration, and 
the effect on GJIC was observed. These results demonstrate that differences exist in 
the cAMP-mediated regulation of GJIC between a cell line consisting of initiated 
cells and a carcinoma derived cell line. 
Introduction 
It has been hypothesized that in the multistep process of tumor formation, a 
decreased gap junctional intercellular communication between genetically altered 
(initiated) cells and surrounding normal cells can induce clonal expansion (1,2). 
This may be due to a reduced growth control via gap junctions of adjacent (non-
transformed) cells (3,4). Gap junctions are intercellular channels, permitting small 
metabolites, ions and second messengers to pass to neighbouring cells. How the 
functioning of gap junctions is regulated is still largely unknown but several groups 
have suggested that a changed phosphorylation level of the gap junction proteins 
(connexins) plays an essential role in the inhibition (5,6) or stimulation of GJIC (7). 
These changes in phosphorylation level can be achieved by (de)activation of protein 
kinases, however the mechanisms controlling this way of regulation are unknown. 
Changes in second messenger concentrations like intracellular calcium (8) and 
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cAMP (9) could be involved. Alterations in these parameters or the responses of 
enzymes to second messengers could play a part in the presumed role of GJIC in 
the process of tumor formation. This is supported by the finding of reduced 
intracellular cAMP concentrations in mouse hepatocytes treated with GJIC-inhibit-
ing agents (10), and by the observation that cAMP stimulating agents can counteract 
tumor promoter-mediated inhibition of GJIC (10,11). This suggests a role of cAMP 
or cAMP-dependent enzymes (such as protein kinase A) in the regulation of GJIC. 
Furthermore, changes in the level of expression and/or the functioning of a cell 
adhesion molecule, like E-cadherin, could be involved (12). 
In mouse keratinocytes during the process of tumor formation, GJIC declines 
with the progressing stage of this process (12). Elevated extracellular calcium 
concentrations were capable of restoring GJIC of papilloma and carcinoma derived 
cell lines to the higher GJIC levels of primary keratinocytes and initiated cells. 
These differences in Ca2+e-dependency are partially the result of changed Ca2+r 
dependent processes (Jansen et al., unplubished results). To determine if differences 
exist between a cell line consisting of initiated cells (3PC) and a carcinoma derived 
cell line (CA3/7) in the role of cAMP-mediated processes in the regulation of GJIC, 
we studied the role of cAMP and protein kinase A (PKA) in the regulation of GJIC 
in these cell lines. In addition we studied the effects of cAMP/PKA-modulating 
agents on connexin43 phosphorylation and connexin43 localization. Because 
cAMP/PKA might exert its effect by changing the intracellular calcium ([Ca2+]j) 
concentration (13-15) we also studied effects of cAMP/PKA-modulating agents on 
[Ca2+]i in both cell lines. Finally, the role of cAMP/PKA in the regulation of the 
amount and localization of the cell adhesion molecule E-cadherin were studied. 
Results 
Agents which raised the intracellular cAMP level by stimulation of cAMP synthesis 
(forskolin) or by inhibition of cAMP break down (IBMX) had no effect on the 
GJIC level of 3PC cells (data not shown) while they increased the GJIC level in the 
CA3/7 cell line under low Ca2+e conditions (Fig.lA). Forskolin (50 uM), which 
raised the GJIC level in CA3/7 cells more effectively within 90 minutes than IBMX 
(100 uM), did not increase the GJIC level of CA3/7 cells under high Ca2+e condi-
tions. Because cAMP exerts its effect by activation of protein kinase A (PKA), the 
effects of a specific activator (SpcAMP) (20), and a specific PKA inhibitor 
(RpcAMP) (20) on GJIC were studied in both cell lines. Exposure to 100 \xM 
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SpcAMP for 90 minutes, did not change the GJIC level in 3PC cells under low 
Ca2+e conditions. SpcAMP increased the GJIC level in CA3/7 cells under low Ca2+e 
conditions comparable to the increase of GJIC in forskolin treated cells (Fig.IB). 
Under high Ca2+e conditions, SpcAMP did not increase the GJIC level in both cell 
lines (data not shown for 3PC cells). Inhibition of cAMP-dependent protein kinase 
by 100 |aM RpcAMP had no significant effect on the GJIC level in both cell lines 
under high Ca2+e conditions. Under low Ca2+e conditions, this agent decreased the 
GJIC level in 3PC cells, and had no effect on the GJIC level in CA3/7 cells 
(Fig.lC). 
B 
Figure 1: The effect of cAMP/PKA modulators 
on GJIC in CA3/7 cells and 3PC cells. A: the 
effect of 50 uM forskolin (o) and 100 uM 
IBMX (A) on GJIC in CA3/7 cells. B: the 
effect of 100 uM SpcAMP on GJIC in 3PC 
cells (A) and CA3/7 cells (o). C: the effect of 
100 uM RpcAMP on GJIC in 3PC cells (A) and 
CA3/7 cells (o). GJIC was determined under 
low (open symbols) and high (closed symbols) 
Ca2+. conditions. 
80 100 
50 
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Because cAMP or cAMP-dependent protein kinase can influence the 
intracellular calcium concentration ([Ca2+];) (13,14), the effects of forskolin, 
SpcAMP and RpcAMP on [Ca2+]j were studied in both cell lines under Ca2+e 
conditions in which these agents affected GJIC (Fig.2). In 3PC cells only forskolin 
significantly increased [Ca2+]; (Fig.2A). In CA3/7 cells under low Ca2+e conditions, 
both SpcAMP and RpcAMP increased [Ca2+]; significantly, and only after longer 
exposure times forskolin significantly increased [Ca2+]i at some time-points 
(Fig.2B). Under high Ca2+e conditions, these agents did not affect the [Ca2+]j in 
CA3/7 cells. 
0 20 40 SO SO 100 
Time (mln) 
Figure 2: The effect of 50 uM forskolin (o), 100 uM SpcAMP (A), and 100 uM RpcAMP (D) on [Ca2*], 
in 3PC cells (A) and in CA3/7 cells (B) under low (open symbols) and high (closed symbols) 
extracellular calcium conditions. 
PKA could play a role in the phosphorylation of the most abundant gap junction 
protein in these cells, Cx43 (12). In Fig.3 and Table 1 is shown that forskolin 
stimulated the phosphorylation of Cx43 in both cell lines under high Ca2+e condi-
tions, and in 3PC cells under low Ca2+e conditions. Exposure of CA3/7 cells to 
forskolin under low Ca2+e conditions resulted however in a decreased Cx43 
phosphorylation. Exposure of 3PC cells to SpcAMP under low Ca2+e conditions, and 
CA3/7 cell under both low and high Ca2+e conditions, resulted in an increased 
phosphorylation level of Cx43. RpcAMP increased Cx43 phosphorylation in both 
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Figure 3: Western blot analysis of connexin43 in 3PC cells (A and C) and in CA3/7 cells (B and D) 
after 90 minutes of exposure under low (A and B) or high (C and D) extracellular calcium conditions. 
c=control (untreated) cells, f= 50 uM forskolin; sp= 100 uM SpcAMP; and rp= 100 uM RpcAMP. 
Calcium 
3PC CA3/7 
LOW 
41 
53 
48 
50 
HIGH 
60 
77 
66 
70 
LOW 
28 
22 
31 
32 
HIGH 
56 
84 
82 
65 
Control 
Forskolin (50 uM) 
SpcAMP (100 uM) 
RpcAMP (100 uM) 
Table 1: The effects of cAMP/PKA modulators on the percentage phosphorylated Cx43 in 3PC cells and 
in CA3/7 cells. The [Ca2+]c was 0.05 mM and 1.20 mM for low and high calcium medium, respectively. 
cell lines under both low and high Ca2+e conditions. The results of the Cx43 
Western analysis are summarised in Table 2. 
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The location of this gap junction protein might be changed as a result of 
exposure of the cells to cAMP/PKA-modulating agents. The effects of the used 
agents on Cx43-linked immunofluorescence under both Ca2+e conditions are shown 
in Fig.4 and Table 2. High Ca2+e conditions increased the intensity of Cx43-linked 
immunofluorescence in both cell lines on the plasma membrane (Fig.4; A2, B2). 
» 
Figure 4: Immunostaining of Cx43 in 3PC cells (A) and in CA3/7 cells (B). Representive pictures are 
shown of cells under low (A1,B1,B3) or high (A2.B2) Ca2+C conditions; control staining (A1.B1); a high 
calcium-induced increased staining ( t in Table 2, pictures A2,B2); and an increased staining by of 
forskolin or SpcAMP (T, picture B3). Narrow arrow heads mark examples of staining on the mem-
branes, broad arrow head marks examples of cytosolic immunostaining. In addition to the specific 
staining (examples marked by arrow heads), non-specific autofluorescence of the cells, due to the long 
exposure time of the films, can be seen. Bar = 25 um. 
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Forskolin and SpcAMP did not change Cx43-linked immunostaining on the plasma 
membrane of 3PC cells under both Ca2+e conditions (data not shown). Both 
forskolin and SpcAMP increased the intensity of the immunostaining on the plasma 
membrane of CA3/7 cells under low Ca2+e conditions (Fig.4; B3), whereas these 
agents had no effect on the staining intensity under high Ca2+e conditions (data not 
shown). Under both Ca2+e conditions, RpcAMP had no effect on Cx43-linked immu-
nostaining in both cell lines (data not shown). 
AGENT 
(MM) 
3PC CA3/7 
Calcium GJIC1 Cx432 Cx43 GJIC' Cx432 Cx43 
(mM) phosphorylation location3 phosphorylation location3 
Control 
Control 
Forskolin 
(50) 
Forskolin 
(50) 
SpcAMP 
(100) 
SpcAMP 
(100) 
RpcAMP 
(100) 
RpcAMP 
(100) 
0.05 
1.20 
0.05 
1.20 
0.05 
1.20 
0.05 
1.20 
100% control 
control 
T 
T 
T 
100% 
TT 
T 
= 
t 
= 
= 
control 
control 
I 
T 
T 
T 
T 
T 
Table 2: Effect of several agents on GJIC, Cx43-phosphorylation and on Cx43-immunstaining in the cell 
lines 3PC and CA3/7. 1: Compared to control-L (= 100%) Symbols =,T,i represent an unchanged, ah 
increased or a decreased GJIC respectively; 2: Compared to the control under the same Ca2+ conditions, 
Symbols =,T,-l represent an unchanged, an increased or a decreased Cx43-phosphorylation respectively; 
3: Compared to the control under the same Ca2t conditions, Symbols =, t represent an unchanged or an 
increased intensity of immunostaining respectively. 
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Because in mouse keratinocytes GJIC is also regulated by the cell adhesion 
molecule E-cadherin (12), we studied the effect of the used cAMP/PKA-modulators 
on the amount and location of E-cadherin in both cell lines. High Ca2+e conditions 
increased E-cadherin immunostaining on the plasma membrane of both cell lines 
compared to low Ca2+e conditions, whereas the used cAMP/PKA-modulators had no 
effect on the immunostaining under both Ca2+e conditions (data not shown). The 
amount of E-cadherin was not changed by an increased [Ca2+]e, nor by the used 
cAMP/PKA-modulators as determined by Western analysis (data not shown). 
Discussion 
This study shows that differences exist between a cell line consisting of 
initiated cells and a carcinoma derived cell line in the regulation of GJIC by cAMP-
dependent processes. We also demonstrated that these differences can be associated 
with differences in the cAMP-dependent regulation of the connexin43 localization 
in the cells. No clear relationship was observed between the level of GJIC and the 
level of Cx43 phosphorylation. Finally, the amount and localization of the cell 
adhesion molecule E-cadherin were not directly regulated by modulators of the 
cAMP/PKA-dependent signal transduction route. 
To study possible changes in the cAMP-regulated GJIC in 3PC cells and 
CA3/7 cells, we exposed both cell types to agents which increase the cAMP 
concentration and determined the effects on GJIC. The high GJIC level in 3PC cells 
under both Ca2+e conditions could not be increased by IBMX and forskolin, whereas 
the GJIC between the cells with a low GJIC level (CA3/7) could be increased by 
these agents. The specific activator of PKA, SpcAMP, induced a GJIC increase 
comparable to the forskolin-induced GJIC increase, suggesting that the forskolin-
mediated increase of GJIC is a result of the activation of PKA. Exposure of 3PC 
cells to the specific PKA inhibitor RPcAMP, resulted in a decreased GJIC level 
under low Ca2+e conditions, while under high Ca2+e conditions the GJIC level 
remained unchanged. These results suggest that PKA stimulates GJIC. Furthermore, 
they suggest that a change to high Ca2+e conditions antagonize against inhibition of 
GJIC by PKA activity inhibitors. These results support the findings of several 
groups, that in mammalian cardiac muscle cells and in mouse hepatocytes, the high 
GJIC level could not be increased by cAMP increasing agents (10,21). Probably, in 
cells with a high GJIC level, the cAMP-dependent signal transduction route is 
already optimal stimulated. An increased GJIC after exposure of cells (with a high 
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GJIC level) to cAMP increasing agents has however been reported for Syrian 
hamster embryo cells (11,22), and for rabbit gastric epithelial cells (23), suggesting 
that differences in the role of cAMP/PKA in the regulation of GJIC is cell type 
dependent. 
Because cAMP/PKA can change [Ca2+], by either affecting Ca2+ release from 
intracellular stores (13,15) or by effecting membrane Ca2+ pumps (24), we deter-
mined the effects of cAMP/PKA-modulating agents on [Ca2+]j in both cell lines. 
Forskolin increased directly (3PC) or after longer exposure times (CA3/7, after 60-
80 minutes) [Ca2+]i in both cell lines under low Ca2+e conditions. Under these 
conditions, the GJIC level remained unchanged (3PC) or was already after 15 
minutes of exposure 35% increased (CA3/7). Furthermore both RpcAMP and 
SpcAMP increased [Ca2+]j rapidly in CA3/7 cells under low Ca2+e conditions. The 
GJIC level in CA3/7 cells was increased by SpcAMP exposure, but not by 
RpcAMP exposure under these conditions. Furthermore, RpcAMP decreased the 
GJIC level in 3PC cells under low Ca2+e conditions, while no effect on [Ca2+]j was 
observed. All these results suggests that the effect of cAMP/PKA modulating agents 
on GJIC is not mediated via changes of [Ca2+](. 
One possible way by which PKA can stimulate GJIC in mouse keratinocytes, 
is by changing the phosphorylation level of Cx43. The capacity of PKA to phospho-
rylate gap junction proteins has been reported for Cx32 and Cx26 in hepatocytes 
(25,26). Activation of PKA in 3PC cells under low Ca2+e conditions by forskolin or 
SpcAMP resulted in an increased Cx43 phosphorylation. In CA3/7 cells Cx43 
phosphorylation was induced by SpcAMP exposure and not by forskolin exposure. 
The reason for this discrepancy is unknown. When the effects of the used 
cAMP/PKA modulators on GJIC are compared with the effects on Cx43 
phosphorylation, no association can be found. This is concistent with earlier 
findings which showed that no relationship exists between the effects of (possible) 
tumor promoters on GJIC and on Cx43 phosphorylation in the same cell lines (27). 
Analysis of the phosphorylation on specific amino acid residues of Cx43 after 
exposure of the cells to cAMP/PKA-modulating agents could give a definite clue to 
whether such relationship exists at all. The hyperphosphorylation of Cx43 in cells 
exposed to the PKA inhibitor RpcAMP suggests that Cx43 is phosphorylated by 
(an) other protein kinase(s), whose activity is (in)directly regulated by PKA. 
Besides effects on Cx43 phosphorylation, PKA might change GJIC by 
changing the location of Cx43 in the cells. Forskolin and SpcAMP increased the 
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intensity of Cx43 immunostaining in CA3/7 cells under low Ca2+e conditions, which 
correlates with an increased GJIC level. This is consistent with the findings that the 
Cx43-linked immunostaining on membranes of hepatocytes could be increased by 
forskolin (28) and by 8-BrcAMP treatment (29). No forskolin- or SpcAMP-induced 
increase of immunofluorescence intensity could be observed in 3PC cells under low 
Ca2+e conditions, nor in both cell lines under high Ca2+e conditions, which correlates 
with the observed effects on GJIC. These results confirm the findings of Mehta et 
al. (28) that in hepatocytes with a basal high GJIC level, both GJIC and the amount 
of Cx43 mRNA could not be increased by forskolin treatment. 
In conclusion this study shows that differences exist between a cell line 
consisting of initiated cells and a carcinoma-derived cell line in the regulation of 
GJIC by cAMP/PKA-modulating agents. Under conditions in which the GJIC level 
was low in CA3/7 cells, GJIC could be increased by PKA-activating agents, in 
concurrence with an increased Cx43 staining on the cell membrane. A high GJIC 
level in both cell types could not be further increased by PKA-activating agents. 
Under low Ca2+e conditions, GJIC could be inhibited in 3PC cells by PKA-inhibi-
tion. Finally, no relationship was found between effects of cAMP/PKA-modulating 
agents on GJIC and their effects on [Ca2+]j or Cx43 phosphorylation. 
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The use of initiated cells as a test system 
for the detection of inhibitors of 
gap junctional intercellular communication 
This chapter is based on the paper: L.A.M.Jansen and W.M.F Jongen (1996) The use of initiated cells as 
a test system for the detection of inhibitors of gap junctional intercellular communication. 
Carcinogenesis, 17, 333-339. 
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Abstract 
The effects of five non-mutagenic carcinogens 1) Aroclor 1260, 2) benzoyl peroxide 
(BP), 3) phenobarbital (PB), 4) 12-o-tetradecanoyl-phorbol-13-acetate (TPA) and 5) 
l,r-(2,2,2-trichloroethylidene)bis[4-chlorobenzene] (DDT) on gap junctional 
intercellular communication (GJIC) were tested in a cell line consisting of initiated 
cells (3PC). Four agents suspected of tumor promotion activity 1) o-anisidine, 2) 
clofibrate, 3) L-ethionone and 4) d-limonene were also tested for their effects on 
GJIC. Finally sodium fluoride (NaF), of which the carcinogenic property is still 
unclear, was tested for its effects on GJIC in the 3PC cell line. Four from the five 
selected tumor promoters (Aroclor 1260, BP, DDT and TPA) decreased GJIC 
between these initiated epidermal cells. The four non-mutagenic carcinogens with 
tumor promoting activity in vivo (o-anisidine, clofibrate, L-ethionine and d-
limonene) all inhibited GJIC, whereas NaF had no effect. Seven compounds (o-
anisidine, aroclor 1260, BP, DDT, L-ethionone, d-limonene and TPA) had a dose-
dependent as well as time-dependent inhibitory effect on GJIC. Under the experi-
mental conditions used, clofibrate showed only a dose-related inhibition of GJIC. PB 
showed no inhibitory effect on GJIC in the 3PC cell line. In order to determine the 
role of biotransformation in the tumor promoting activity of PB, its effect on GJIC 
was also examined in the presence of an aroclor 1254 induced rat liver homogenate 
(S9 mix) and in the hepatoma cell line HepG2. In the presence of rat liver 
homogenate PB decreased GJIC in the 3PC cell line, whereas in the HepG2 cells PB 
showed a time- and dose-dependent inhibitory effect. To study the potential 
differences in susceptibility of cells representing different stages in the process of 
tumor formation the effect of the selected tumor promoters on GJIC were also 
investigated in primary mouse keratinocytes and in a mouse skin carcinoma derived 
cell line (CA3/7). Primary keratinocytes were sometimes more (BP and clofibrate) 
and sometimes less sensitive (efhionin and limonene) for inhibitory effects on GJIC 
compared to the effects in the cell line 3PC. Except for TPA and anisidin, GJIC 
between the CA3/7 cells was less affected by the selected agents compared to the 
3PC cell line. Firstly, these results show that, during the process of tumor formation 
the susceptibility of cells to inhibition of GJIC by tumor promoters is variable. 
Overall the CA3/7 cells are less sensitive compared to 3PC cells. The susceptibility 
of primary keratinocytes is variable compared to 3PC cells, depending on the agent 
used. Secondly, these results show that GJIC is a valid parameter for testing tumor 
promotion activity of compounds. And finally, this study demonstrates, that mouse 
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keratinocyte cell lines could serve as an in vitro model for the detection of non-
mutagenic carcinogens with diverse target organs in vivo. For this use the cell line 
consisting of initiated cells (3PC) is more sensitive than the carcinoma derived cell 
line CA3/7. 
Introduction 
Chemical induced tumor formation is a process in which various stages can be 
distinguished. During the initiation stage, a carcinogen-induced mutation of the 
DNA takes place. The following promotion stage involves processes in which 
initiated cells undergo clonal expansion to form premalignant lesions. It has been 
postulated that inhibition of intercellular communication may be a causal factor in 
this process. Several lines of evidence suggest an important role for gap junctional 
intercellular communication (GJIC) in the process of tumor formation. Firstly, a 
large proportion of compounds with tumor promoting capacity were shown to 
decrease GJIC in various mammalian cell types (1-3). Secondly, several groups (4-
7) reported a lack of GJIC between transformed and non-transformed cells permit-
ting transformed cells to maintain autonomous growth. In the third place, by 
stimulation of junctional communication with normal cells, the transformed 
phenotype of transformed cells can be suppressed (5,8). 
One important aspect of tumor promoters is their tissue specificity. The 
toxico-kinetic behaviour as well as the metabolism of compounds in the target organ 
are important determinants of the toxicity (or carcinogenicity). Therefore, the use of 
cells from the target tissue forms the basis of several in vitro systems to determine 
the effect of compounds on GJIC. Some of these systems use primary cell cultures 
(9-11) whereas others use cell lines like the Chinese hamster V79 cell line (1). Our 
working hypothesis is that the effect of agents, suspected of tumor promoting 
activity on GJIC, should be tested in a system consisting of cells which are the 
target cells for tumor promoters, i.e. initiated cells. These cells could be more 
sensitive to the effects of tumor promoters (12,13). To test this hypothesis we used 
the mouse epidermal cell line 3PC which was derived from primary mouse keratino-
cytes, exposed to DMBA in vitro and selected under high calcium conditions (14). 
These cells are considered initiated cells because of their resistance to the differenti-
ation-inducing effect of calcium, which has been suggested to be a critical event 
associated with initiation of carcinogenesis in mouse skin (15), and on the other 
hand have a GJIC level at low calcium conditions comparable with primary 
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keratinocytes (16). Because biotransformation activity of 3PC cells is very low, 
compounds not directly affecting GJIC in the 3PC cell line were tested for their 
potential to inhibit GJIC in two ways: A) in the presence of an aroclor 1254 induced 
rat liver homogenate, and B) in the hepatoma cell line HepG2 (17). In this way, 
both the direct effect on GJIC and the effects after biotransformation of compounds 
can be determined. To validate our system we tested five non-genotoxic carcinogens 
with known capacity to decrease GJIC in in vitro systems (Table 1). Furthermore, 
four non-genotoxic agents with carcinogenic capacity in vivo, and one agent of 
which the carcinogenic property is still unclear (NaF), were tested for their effect on 
GJIC in the mouse epidermal cell line 3PC. 
Table 1: Literature overview of tumor related properties of the selected agents. 
Agent 
Aroclor 1260 
BP 
DDT 
TPA 
PB 
o-Anisidine 
L-Ethionine 
d-Limonene 
Clofibrate 
NaF 
Inhibition GJIC 
in vitro" 
+ 18,19 
+ 1,25 
- 26 
+ 2,18,19,31 
+ 2,18,19 
- 2,40,41 
+ 1,18,32,42 
? 
? 
? 
? 
7 
Mutagenicity 
(S. typhimurium 
assay-test)b 
+/- 20 
- 21-23 
- 23,26,28 
- 19,32 
- 36,37 
- 43 
+ 46,47* 
- 48 
- 50 
- 43 
- 57 
- 61 
Tumor promoter/ 
carcinogen in vivo0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
21,24 
28 
25,29,30 
33-35 
30,38,39 
33,44-45 
47,49 
50,51 
52-54 
55,56 
58-60 
62 
63 
Main target 
tissue in vivo 
liver 
skin 
liver 
skin 
liver 
bladder 
liver 
kidney 
liver 
bone 
a) + = i GJIC, - = T or no effect on GJIC, ? = unknown. 
b) - = not mutagenic; +/- = only weakly mutagenic. 
c) only mutagenic after metabolic activation (46,47). 
d) + = tumor promotion or carcinogenic action, - = no such action. 
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Table 2: Inhibition of GJIC in the cell line 3PC after exposure 
Agent 
Aroclor 1260 
Benzoyl Perox-
ide 
DDT 
TPA 
PB 
o-Anisidine 
L-Ethionine 
d-Limonene 
Clofibrate 
NaF 
Concentration 
(ug/ml) 
200 
500 
1000 
10.0 
40.0 
80.0 
2.0 
5.0 
10.0 
1.0 
2.0 
4.0 
500 
1000 
1232 
1848 
2464 
204 
408 
816 
136 
272 
681 
51 
126 
250 
420 
1050 
2100 
7.5 
111 
76 
43 
88 
69 
52 
22 
13 
6 
23 
10 
5 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
91 
82 
28 
107 
82 
71 
99 
84 
83 
57 
79 
69 
90 
92 
79 
78 
75 
99 
40 
40 
33 
9 
2 
32 
8 
9 
112 
96 
101 
15 
* 
* 
* 
$ 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
to several 
GJIC 
compounds. 
(percentage of control) 
Time (min) 
45 
35 
55 
10 
74 
59 
53 
78 
62 
27 
49 
62 
27 
90 
101 
76 
59 
27 
50 
41 
35 
27 
10 
3 
22 
6 
6 
113 
96 
83 
* 
* 
* 
$ 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
70 
10 
8 
6 
47 
37 
28 
55 
52 
24 
66 
46 
20 
79 
37 
23 
64 
48 
33 
22 
6 
tox 
15 
97 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
$ 
* 
* 
* 
* 
* 
5 
13 
tox 
35 
29 
23 
55 
42 
7 
66 
47 
22 
105 
70 
38 
21 
58 
47 
28 
90 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
$ 
* 
* 
* 
* 
* 
# Significantly different from control (100%) bij Analysis of Variance (ANOVA) (* = p < 0.001, 
$ = p < 0.01) 
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To study the changes in susceptibility during the process of tumor formation for 
inhibition of GJIC by tumor promoters, we compared the effects of these non-
genotoxic carcinogens on GJIC in 3PC cells with those in primary mouse skin 
keratinocytes and a mouse skin carcinoma derived cell line (CA3/7). 
Results 
The agents used in this study are considered to be non-mutagenic carcinogens due to 
their non-mutagenicity in S. tvphimurium and their carcinogenic effects in in vivo 
experiments (summarized in Table 1). Table 2 shows that four of the five com-
pounds known to decrease GJIC in various test systems had also inhibitory effects 
on GJIC in the mouse epidermal cell line 3PC (Aroclor 1260, BP, DDT, TPA). The 
four compounds selected for their non-mutagenic carcinogenic effects in vivo (o-
anisidine, clofibrate, L-ethionone and d-limonene) all decreased GJIC in the 3PC 
cell line. Only the tumor promoter phenobarbital and NaF did not affect GJIC. From 
the agents with inhibitory effects on GJIC, seven compounds showed a time- as well 
as dose-dependent inhibition of GJIC (Table 2). Under the experimental conditions 
used here, clofibrate showed only a dose-dependent inhibition of GJIC. At all 
concentrations tested, both PB and NaF did not significantly decrease GJIC after 90 
minutes (Table 2). 
S9 Cell line 
3PC 
3PC 
3PC 
HepG2 
HepG2 
Concentration 
PB (ug/ml) 
0 
1000 
1000 
500 
1000 
15 
94 
100 
63 
68 
40 
GJIC (% of control) 
Time (min.) 
# 
*** 
* 
*** 
45 
97 
107 
58 
42 
nd 
# 
*** 
*** 
Table 3: GJIC in the cell lines 3PC and HepG2 after exposure to PB. # Significantly different from 
control (100%) bij Analysis of Variance (ANOVA) (* = p < 0.03, *** = p < 0.001), nd = not deter-
mined, loss of cell viability 
To determine if PB needs metabolic activation to affect GJIC, the effect of 
PB on 3PC cells was tested in the presence of aroclor 1254 induced rat liver 
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homogenate (S9 mix). Addition of S9 mix did inhibit GJIC during exposure of 3PC 
cells to PB (Table 3). The effect of PB on GJIC was also determined in the 
hepatoma cell line HepG2. These cells were shown to have cytochrome P450 
enzyme activity (17) whereas the metabolic capacity of the 3PC cells is very low 
(data not shown). In the cell line HepG2, PB and/or PB metabolites inhibited GJIC 
in a dose- as well as time-dependent manner. 
To study the involvement of extracellular calcium in the inhibition of GJIC, 
3PC cells were cultured for 24 hours in high calcium medium (1.2 mM). As for the 
low calcium conditions, cells were exposed to tumor promoters and the effect on 
GJIC was determined. Except for a slight decreased sensitivity for BP induced GJIC 
inhibition, high extracellular calcium conditions had no effect on the inhibition of 
GJIC by the tumor promoters (data not shown). 
To study potential differences in susceptibility of cells representing different 
stages in the process of tumor formation, the effect of the selected tumor promoters 
on GJIC was tested in mouse primary keratinocytes and in a mouse skin carcinoma 
derived cell line (CA3/7). Table 4 shows that all tumor promoters which inhibited 
GJIC in the 3PC cell line, also affected GJIC in the carcinoma derived cell line 
CA3/7. Except for TPA and anisidin, inhibition of GJIC by the tumor promoters 
was significantly less in the CA3/7 cell line compared to the 3PC cell line, but still 
in the same order of magnitude. In primary keratinocytes GJIC was significantly 
more inhibited at short exposure times by BP, clofibrate and DDT, although at 90 
minutes of exposure to DDT the degree of GJIC inhibition was comparable with the 
results in the 3PC cell line. In the primary cells, TPA and Aroclor 1260 caused only 
at longer exposure times a stronger, respectively less strong inhibition of GJIC 
compared to the effect obtained with 3PC cells. Limonene had a much weaker effect 
on GJIC in primary cells compared to the effect in both cell lines. Finally, ethionine 
did not significantly affect GJIC in primary keratinocytes. 
Discussion 
In the present study, we used initiated cells to detect non-mutagenic carcinogens in 
vitro, based on the hypothesis that these cells are the target cells for tumor promo-
ters. Four out of five tumor promoters with known GJIC-inhibiting capacity, 
decreased GJIC in the cell line consisting of initiated mouse epidermal cells (Table 
2). Using higher (non-toxic) concentrations (BP, TPA) or the same concentrations 
(Aroclor 1260, DDT) compared to others (1,17-19,25,26,31), we could detect 
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Tabel 5: Remaining percentage (control = 
AGENT (ug/ml) TIME (min) 
Aroclor 1260 (200) 
Benzoyl Peroxide 
(40) 
DDT (5) 
TPA(2) 
Phenobarbital (1000) 
Anisidine (1848) 
Clofibrate (51) 
Ethionine (408) 
Limonene (136) 
15 
45 
70 
90 
15 
45 
70 
90 
15 
45 
70 
90 
15 
45 
70 
90 
15 
45 
90 
15 
45 
70 
90 
15 
45 
70 
15 
45 
70 
90 
15 
45 
70 
* = significantly different from control 
control in same cell type, 
under the same conditions 
p <0.01; *** 
p <0.001. 
= 100%) of GJIC in 
3PC 
82 
55* 
8* 
13* 
82 
59* 
37* 
29* 
84 
62* 
52* 
42* 
79" 
62* 
46* 
47* 
92 
101 
105 
78* 
59* 
37* 
38* 
30* 
22* 
15* 
40* 
41* 
48* 
47* 
33* 
27* 
22* 
in same cell type, 
cell treated with different tumor promoters. 
CA3/7 
79" 
56' 
37*'*" 
40*"* 
97 
73*'*" 
54*'*** 
48*"* 
90 
72* 
66**'* 
68**** 
66* 
50* 
31* 
37* 
107 
106 
96 
8 1 " 
67* 
47*.*" 
47* 
6 1 * ' " 
55*"* 
42*"' 
62**" 
71*"* 
68**" 
69*"* 
53*"* 
50*"* 
4 3 * " ' 
p <0.001; 
= significantly different from 
primimary keratino-
cvtes 
76* 
46* 
NT 
30*"* 
15*"* 
13*"" 
NT 
NT 
69"*** 
41**" 
NT 
52* 
55* 
36*"* 
NT 
25*" ' 
NT 
104 
98 
61**" 
49' 
NT 
45* 
12*"* 
5*"* 
NT 
100*** 
115"" 
NT 
120'" 
6 7 " ' " 
8 1 " ' 
88*" 
** = significantly different from 
remaining GJIC in 3PC cell line 
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inhibition of GJIC after shorter exposure times. The fifth positive control, phenobar-
bital, decreased GJIC only after metabolic activation by aroclor 1254-induced rat 
liver homogenate. Several groups have reported inhibition of GJIC after exposure of 
cells to PB (see Table 1) whereas others did not find decreased GJIC in Chinese 
hamster V79 fibroblasts (2,41). One possible explanation is that PB needs to be 
metabolized and that the metabolites inhibit GJIC. In liver cells, enzyme systems 
involved in biotransformation are sufficiently active. Indeed, inhibitors of 
cytochrome P450 monooxygenase prevented inhibition of intercellular communica-
tion by PB (65,66), suggesting a role of PB-metabolites in the PB-induced inhibition 
of GJIC. As we demonstrated with DDT and Aroclor 1260, the DMBA-initiated 
mouse epidermal cell line 3PC is sensitive for the inhibitory effect of direct acting 
liver tumor promoters on GJIC. 
To clarify the contradictory findings with PB we first incubated PB with an 
aroclor 1254-induced rat liver homogenate to convert PB into its metabolic products. 
Exposure of 3PC cells to these metabolites decreased GJIC to almost 50% of control 
levels. In HepG2 hepatoma cells (with sufficient metabolic capacity), PB affects 
GJIC without the presence of S9 mix (Table 3). These results point to an essential 
role of metabolic activation of PB to affect GJIC. It shows the need for appropriate 
metabolizing systems in the screening of the potential of agents to inhibit GJIC. 
Four compounds with established tumor promoting activity, based on data of in vivo 
carcinogenicity and non-mutagenicity, were selected and tested for their effect on 
GJIC in the 3PC cell line. No information is available as to whether the effects of 
these agents on GJIC in other systems is tested. All four compounds decreased GJIC 
in a dose-dependent way in the 3PC cell line (Table 2). Except for clofibrate, they 
also showed a time-dependent inhibition of GJIC in 3PC cells. 
3PC cells were shown to be resistant for the induction of differentiation by an 
increase of extracellular calcium (14). The level of GJIC in these cells is also not 
influenced by a change of extracellular calcium from 0.05 to 1.2 mM (16). Except 
for a slight decreased sensitivity for BP induced GJIC inhibition, high extracellular 
calcium conditions did not affect inhibition of GJIC by the selected tumor promoters 
compared to low calcium conditions (data not shown). This finding agrees with the 
results of other groups obtained with TPA and DDT (73,86). Madhukar et al showed 
however that TPA as well as DDT increased intracellular calcium in hamster 
fibroblasts (87). This suggests that mobilisation of calcium from intracellular stores 
may affect GJIC, as the non-phorbol ester tumor promoter thapsigargin does (88,89). 
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To determine if initiated cells are more susceptible for inhibition of GJIC 
then cells in other stages of carcinogenesis, we compared the effects of several 
agents on GJIC in primary keratinocytes and in a cell line of carcinoma cells 
(CA3/7, Table 4). The results presented here show that the cell line of initiated cells 
(3PC) is more sensitive for inhibition of GJIC by almost all selected tumor promo-
ters than the carcinoma derived cell line CA3/7. The primary keratinocytes were 
sometimes more (for BP, clofibrate, and in a lesser extend TPA) or less (aroclor 
1260, ethionone and limonene) sensitive for inhibition of GJIC by tumor promoters 
than the 3PC cells. GJIC in primary cells was at shorter exposure times more 
affected by DDT then in 3PC cells, but this difference disappeared after 90 minutes 
of exposure. All together, this suggest that during the process of tumor formation, 
depending on the tumor promoter, changes in susceptibility for inhibition of GJIC 
can occur, and that the type of change is strictly confined to the agent used. 
Using some of the known tumor promoters, several mechanisms involved in the 
inhibition of GJIC are studied. Both hyper- and hypophosphorylation of connexins 
are related with changes in levels of GJIC (ref 67-70). The changed phosphorylation 
level of connexins may be a result of the (in)activation of protein kinases. The 
involvement of protein kinases and connexin phosphorylation in the inhibition of 
GJIC has been reported for TPA (71-75), DDT (71,75-77) and PB (73). 
Hyperphosphorylation may affect the functionality of gap junction channels, but it 
may also play a role in the transport of connexins from and to the cell membrane 
(78). Changes in connexin localization was reported in cells treated with TPA 
(69,71,74), PCB (79), PB (79) and DDT (71,75), although other reports showed no 
changes in connexin localization after treatment of cells with TPA (71,73) or DDT 
(71,75). These differing findings may result from the different cell types used. An 
other way tumor promoters may affect GJIC is by the production of reactive oxygen 
radicals as demonstrated for TPA (81-83), PB (82,84), BoP (25,81) and DDT (82). 
These products may cause oxidation of membrane lipids, hereby influencing 
membrane fluidity and subsequent gap junction plaque stability (80). The 
peroxisome proliferator clofibrate (85) may also affect GJIC by reactive oxygen 
products produced in the peroxisomes. Because this is the first time that inhibition 
of GJIC by anisidin, clofibrate, ethionine and limonene is demonstrated, no work is 
done so far on the mechanisms of inhibition of GJIC by these compounds. 
All together, these results show that the DMBA-initiated mouse epidermal 
cell line 3PC can be used as a short-term model for detecting tumor promoters with 
70 
Detection of tumor promoters 
different target organs in vivo. These results also demonstrate that, during the 
process of tumor formation, changes in susceptibility for inhibition of GJIC by 
tumor promoters occur. The mechanisms underlying these changes could be an 
interesting subject for further research. Finally these results show that o-anisidine, L-
ethionone, d-limonene and clofibrate, but not NaF are potential tumor promoters. 
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Inhibition of gap junctional intercellular communication 
and derealization of the cell adhesion molecule 
E-cadherin by tumor promoters 
This chapter is based on the paper: 
L.A.M.Jansen, M.Mesnil, and W.M.F.Jongen (1996) Inhibition of gap junctional communication and 
delocation of the cell adhesion molecule E-cadherin by tumor pormoters. Carcinogenesis, 17, 1527-1531. 
77 
Chapter 6 
Abstract 
The effect of 12-0-tetradecanoylphorbol-13-acetate (TPA) and benzoyl peroxide (BoP) 
on gap junctional intercellular communication (GJIC) and the amount and localization 
of E-cadherin was studied in initiated mouse epidermal cells (3PC) and in carcinoma 
cells (CA3/7) originating from the same cell type. In addition, the localization and 
phosphorylation of connexin43 was studied in both cell lines and in primary 
keratinocytes. GJIC inhibition by TPA and BoP was stronger in primary keratinocytes 
compared to both cell lines. BoP strongly decreased the amount of E-cadherin protein 
and the level occurring in the membranes in both cell lines, whereas TPA caused a 
translocation of E-cadherin from the membrane towards the cytosol, without decreasing 
the total amount of E-cadherin present. The effect of both tumor promoters on 
connexin43 phosphorylation and localization was agent- as well as cell-dependent. 
These results show for the first time, that tumor promoters can decrease the quantity 
and membrane localization of E-cadherin in different cell types. 
Gap junctions are intercellular membrane channels, permitting the free exchange of 
small molecules (< 1000 dalton) between the cytosol of neighbouring cells. They are 
thought to play an important role in the maintenance of cell differentiation and 
homeostasis (1). In the multistage process of carcinogenesis, inhibition of gap 
junctional intercellular communication (GJIC *) is considered to be an important event 
during the promotion stage, since it has been shown to be inhibited by various types 
of tumor promoters (2). The mechanisms by which these agents decrease GJIC include 
changes in gap junction protein (connexin) localization and phosphorylation as was 
shown both in vitro (3) and in vivo (4). The cell line 3PC, consisting of initiated 
mouse keratinocytes, has been shown to be a useful tool for testing the tumor 
promoting capacity of agents (5). These cells are more sensitive for the inhibition of 
GJIC by tumor promoters compared to the mouse skin carcinoma-derived cell line 
CA3/7. Primary keratinocytes are, depending on the tumor promoter used, either more 
or less sensitive than 3PC cells. These results suggest changes in susceptibility of cells 
for the inhibition of GJIC by tumor promoters during the process of tumor formation. 
Since in mouse keratinocytes GJIC is also regulated by the cell adhesion 
molecule E-cadherin (6), and the phorbol ester 12-0-tetradecanoylphorbol-13-acetate 
(TPA) was shown to inhibit cell assembly in various cell types (7), we studied the 
effect of two tumor promoters (TPA and benzoyl peroxide (BoP)) on the quantity and 
localization of E-cadherin in the cell lines 3PC and CA3/7 in relation to effects on 
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GJIC levels. Mouse primary keratinocytes were harvested and cultured as described (6). 
The cell lines 3PC and CA3/7 were cultured as previously described (8). To study the 
mechanisms of TPA- and BoP-mediated inhibition of GJIC, we first determined the 
effect of both tumor promoters on GJIC levels in the three cell types by the fluorescent 
dye transfer method (6) (Table 1). 
TPA (4 (ig/ml) 
BoP (40 |ig/ml) 
TIME 
(min) 
15 
45 
90 
15 
45 
90 
Prim.Ker. 
45 
64 
75 
85 
87 
nd 
GJIC (% inhibition) 
3PC 
21 
38 
53 
18 
41 
71 
CA3/7 
34 
50 
63 
3 
27 
52 
Table 1: Percentage of inhibition of GJIC in different cell types after exposure to TPA or BoP. The number 
of recipient cells under control conditions (18, 30, and 25 for prim.ker., 3PC and CA3/7 cells, variation < 
7%) was not changed by the solvents used. The solvents and tumor promoters used, had no influence on 
cell viability as determined by the Trypan blue exclusion test. The GJIC capacity is expressed as the 
percentage GJIC inhibition compared to control GJIC (100% at t=o). Prim.Ker.= primary keratinocytes, nd= 
not determined. 
After 90 minutes of exposure to both tumor promoters, the number of communicating 
cells was decreased in both cell lines. Primary keratinocytes were much more sensitive 
for inhibition of GJIC by BoP compared with the two cell lines. For further studies on 
the effects of TPA (4 ug/ml) and BoP (40 ug/ml) on connexin43 (Cx43) and E-
cadherin, cells were exposed for 90 minutes to the agent (except the exposure of 
primary keratinocytes to BoP (45 minutes)), after which either total protein was 
extracted for Western analysis, or the cells were used for immunofluorescence 
experiments. We studied the effects of exposure on the amount of E-cadherin protein 
as examined by Western analysis (4), using for E-cadherin a 10% polyacrylamide gel 
and a first antibody from Sigma (St Louis, MO). As shown in Figure 1, TPA had no 
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effect on the amount of E-cadherin protein 
minutes of exposure to BoP, no E-cadherin 
whereas in primary keratinocytes the 
amount of E-cadherin protein was 
strongly decreased (after 45 min) 
compared to control cells. The film of 
blot A (Fig.l) was exposed longer than 
those exposed to blot B and C. The 
differences in band intensity between 
different cell types therefore suggest a 
lower amount of E-cadherin protein/mg 
total protein in 3PC cells compared to 
the other cell types. 
Immunofluorescence techniques were 
used to study the localization of E-
cadherin protein in the cell lines 3PC 
and CA3/7. The technique used was the 
same as described for connexin43 (4), 
using the same anti-E-cadherin antibody 
as for the Western analysis. In both cell 
lines, under control conditions, the main 
proportion of E-cadherin-linked 
immunofluorescence was found on cell-
cell contact areas (Fig 2; A2, B2: 
narrow arrow heads). TPA caused a 
strong decrease in immunofluorescence 
on these contact areas and an increase 
in immunostaining around the nucleus 
(3PC cells) or in the cytosol (CA3/7 
cells) (Fig 2; A3, B3: broad arrow 
heads). This suggests an effect of TPA 
on E-cadherin localization in the cells, 
irrespective of the cell line used. BoP 
also caused a strong decrease in 
membrane immunofluorescence but 
in all cell types tested. However, after 90 
protein was detectable in both cell lines, 
E-cadherin 
B 
E-cadherin 
E-cadherin 
Fig 1. Western blot analysis of E-cadherin in 3PC 
cells (A), CA3/7 cells (B) and primary 
keratinocytes (C). c= control (untreated) cells, t= 
TPA (4 ug/ml) treated cells, b=BoP (40 ug/ml) 
treated cells. Cells were exposed for 90 min to 
TPA or BoP, except primary keratinocytes 
exposed to BoP (45 min). 20 ug protein per 
sample was applied for each lane. 
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some (point) staining was present in the cytosol of both cell lines (Fig 2; A4, B4: 
broad arrow heads). This immunocytochemistry staining is specific because no staining 
was found in both cell lines when PBS was used instead of a first antibody (Fig. 2; Al, 
B1). The intensity of E-cadherin immunostaining in BoP-treated cells is however much 
lower compared to the clear membrane staining in untreated cells of both cell lines, 
supporting the findings of a strongly decreased amount of E-cadherin as detected by 
Western blotting analysis. The change in localization of E-cadherin caused by TPA and 
BoP suggests that these tumor promoters disturb the function of this cell adhesion 
molecule. This could result in an increase of intercellular space, limiting the 
B 
Fig 2. Immunostaining of E-cadherin in 3PC cells (A) and CA3/7 cells (B). Staining was performed with 
1) untreated cells without first antibody (negative control), 2) untreated cells with first antibody (positive 
control), 3) TPA (4 ug/ml, 90 min.) treated cells and 4) BoP (40 ng/ml, 90 min.) treated cells. Bar is 25 um 
in both series A and B. The film of picture 1A and IB was exposed for a longer time, causing a non-
specific autofluorescence of the cells in these pictures. Narrow arrow heads mark examples of staining on 
the membrane between cells, broad arrow heads mark examples of cytosolic staining in cells. 
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possibility of gap junction channel 
formation (7). In this study no apparent 
change in cell assembly was observed, 
which may be due to the fact that the 
cells were still well attached to the 
culture dishes during the exposure to 
the tumor promoters. 
The mechanisms by which tumor 
promoters affect E-cadherin functioning 
are still unclear, but (in)activation of E-
cadherin bound proteins (like catenins 
or APC (Adenomatous Polyposis Colon 
gene)) may play a role. Catenins are 
proteins which bind to E-cadherin, and 
which are involved in the functioning of 
E-cadherin (9-12). The phosphorylation 
of B-catenin on tyrosine has been shown 
to decrease the E-cadherin functioning 
(13,14). Tumor promoters could change 
the binding of catenins to E-cadherin by 
activation of tyrosine kinases or 
inactivation of tyrosine phosphatases, 
thereby decreasing cell recognition and 
gap junction formation. Another 
molecule binding indirectly to E-
cadherin is the tumor suppressor 
molecule APC. This molecule has been 
shown to associate with catenins 
(15,16), suggesting a possible role of 
APC in the regulation of E-cadherin or 
vice versa. The effect of tumor 
promoters on E-cadherin function may 
generally be caused by affecting APC-
like activity, or the decrease of E-
cadherin function may affect APC-
— NP 
B 
- N P 
Wjr^ . «• •« gggj NP 
Fig 3. Western blot analysis of connexin43 in 
3PC cells (A), CA3/7 cells (B) and primary 
keratinocytes (C). c= control (untreated) cells, t= 
TPA treated cells, b=BoP treated cells. NP=non-
phosphorylated Cx43, Px= phosphorylated Cx43. 
Times of treatment and concentrations were as 
described in Fig.l. 20 ug protein per sample was 
applied for each lane. 
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regulated tumor suppression. 
TPA is known to activate protein kinase C (PKC) (17,18), which was shown to 
decrease the expression of intercellular adhesion molecule 1 (ICAM-1) (19). Lewis et 
al (20) showed that E-cadherin could organise various junctional components through 
PKC. Thus, PKC activity could be changed by tumor promoters directly, as well as 
indirectly by changes in E-cadherin functioning. Furthermore both TPA and BoP 
increase the amount of reactive oxygen species (for references see LJansen and 
W.Jongen, in press) which have been shown to decrease protein tyrosine kinases and 
induce translocalization of E-cadherin in MDCK cells (21). 
Changes in phosphorylation levels or localization of connexins have been 
reported to occur in cells exposed to tumor promoters (3,4). Therefore, the effect of 
TPA and BoP on the phosphorylation and localization of the protein connexin43 
(Cx43), the main connexin in these cells (6), was also studied and compared to the 
effects observed on Cx43 in mouse primary keratinocytes. 
As shown in Figure 3, TPA caused in both cell lines, as well as in primary 
keratinocytes, a hyperphosphorylation of Cx43 (i.e. a decreased intensity of the NP-
band in concurrence with an increase in the intensity of the Px-band). This is consistent 
with earlier findings (3,22). BoP however, decreased Cx43 phosphorylation in both 
primary keratinocytes and in the 3PC cells, as shown by a loss in intensity of the 
phosphorylated (Px) band (Fig 3A & 3C). This agent however, increased Cx43 
phosphorylation in CA3/7 cells (Fig.3B). This suggests that a change of Cx43 
phosphorylation (either hypo- or hyper-phosphorylation) could affect gap junction 
functioning (compare effects TPA and BoP in the CA3/7 cell line). This is consistent 
with other reports associating inhibited GJIC with either hyperphosphorylation of Cx43 
(4,22-24) or, in other cells types, with hypophosphorylation of Cx43 (25). These results 
also suggest that different tumor promoters may have different mechanisms to decrease 
GJIC, depending on the cell type used. By which mechanism tumor promoters change 
Cx43 phosphorylation is not exactly clear, because several protein kinases (PKA, PKC 
and Tyrosine kinase) are involved in the regulation of GJIC, leading to changes in 
Cx43 phosphorylation (for further references, see (5)). 
An other possibility for the mechanisms of GJIC inhibition is the change in 
(amount or) localization of connexins. Figure 4 shows the effects of TPA and BoP on 
immunofluorescence staining of Cx43 in 3PC cells, CA3/7 cells and primary kerati-
nocytes. In untreated cells Cx43 immunostaining is present on the cell membrane. In 
all cell types TPA caused a decrease in Cx43 immunostaining on the membrane. 
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Fig 4. Immunostainihg of connexin43 in 3PC cells (A), CA3/7 cells (B), and primary keratinocytes (C). 
Staining was performed with 1) untreated cells without first antibody (negative control), 2) untreated cells 
with first antibody (positive control), 3) TPA treated cells and 4) BoP treated cells. Bar is 25 urn in all series 
A, B, and C. Times of treatment and concentrations were as described in Fig. 1. The films of pictures number 
1-3, and A4 were exposed for a longer time, causing a non-specific autofluorescence of the cells in these 
pictures. Narrow arrow heads mark examples of staining on the membrane between cells, broad arrow heads 
mark examples of cytosolic staining in cells. 
BoP strongly decreased Cx43 staining in 3PC cells and caused a Cx43 displacement 
from the membrane to the cytosol in CA3/7 cells and in primary keratinocytes. The 
results obtained with TPA are in agreement with other reports, showing that several 
tumor promoters (including TPA) can cause translocation of connexins from the 
84 
Tumor promoters effects on E-cadherin 
membrane to the cytosol or a decreased staining, although these changes do not always 
occur (3,4). A possible explanation for the fact that less intense Cx43 immunostaining 
is found (Figure 4; 3A, 3B, 3C) whereas the amount of Cx43 protein was not 
decreased by TPA (Figure 3) could be that individual connexons or small gap junction 
plaques give rise to less fluorochrome molecules per area unit, resulting in a very low 
fluorescence emission, which is below the visual limit. Taking into account the role of 
E-cadherin in the regulation of GJIC in mouse keratinocytes in general (6), the effects 
on GJIC may be mediated by the effect of the tumor promoters on E-cadherin. Further 
time sequence experiments could determine if the tumor promoter-induced effects on 
E-cadherin precede those on Cx43. 
Overall these results show for the first time, that tumor promoters can decrease the 
quantity and membrane localization of the cell adhesion molecule E-cadherin. These 
results suggest that the loss of E-cadherin functioning could play a role in stages of 
tumor formation before tumor progression, which may lead to a decreased GJIC, which 
in turn is thought to play an important role in carcinogenesis (26). 
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Tumor promoters induce inhibition of gap junctional 
intercellular communication in mouse epidermal cells 
by affecting the localization of 
connexin43 and E-cadherin. 
This chapter is based on the paper: 
L.Jansen, M.Mesnil, J.Koeman, and W.Jongen (1996) Tumor promoters induce inhibition of gap junctional 
intercellular communication in mouse epidermal cells by affecting the localization of connexin43 and E-
cadherin. Environm.Toxicol.Pharmac, 1, 185-192. 
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Abstract 
The molecular and histological effects of tumor promoters on gap junctional 
intercellular communication (GJIC) were studied in three mouse epidermal cell types, 
representing different stages of tumor formation. GJIC was inhibited by most of the 
studied compounds (L-ethionine, d-limonene, o-anisidine, clofibrate, Aroclor 1260 and 
l,l'-(2,2,2-trichloroethylidene)bis[4-chlorobenzene] (DDT)) except NaF and 
phenobarbital (PB). Whatever their effect on GJIC, most of the studied compounds 
increased the phosphorylation state of the gap junction protein expressed in these cells, 
connexin43 (Cx43), as shown by Western analysis. All agents with GJIC inhibiting 
capacity changed the intensity of the immunofluorescent staining of Cx43 on the 
membrane of the cells, whereas NaF and PB had no effect on Cx43 immunostaining. 
No association could be found between the type of change in Cx43 localization 
(changed membrane- and/or cytosolic staining) and Cx43 phosphorylation or GJIC 
inhibition. Because the cell adhesion molecule E-cadherin also regulates GJIC, the 
effects of tumor promoters on E-cadherin protein and -localization were studied. No 
quantitative change could be observed in E-cadherin protein content of cells treated 
with any of the selected agents. However, all agents which decreased GJIC, affected 
E-cadherin immunostaining of the membrane, while PB and NaF had no effect. These 
results show that an association exists between inhibition of GJIC and localization of 
both connexin43- and E-cadherin protein, but not with Cx43 phosphorylation. 
Introduction 
The most commonly accepted theory of chemically induced carcinogenesis, is the 
multistage concept. The initiation stage, in which cells undergo one or more DNA 
mutations, is followed by a promotion stage, in which cells undergo clonal expansion 
to form premalignant lesions (1,2). Inhibition of gap junctional intercellular 
communication (GJIC) has been postulated to be one of the important events which 
take place during the promotional stage. Indeed, it has been shown in vitro (3) and in 
vivo (4) that a large proportion of tumor promoters decrease GJIC as recently reviewed 
by Trosko and Chang (5) and by Budunova and Williams (6). Several other lines of 
evidence suggest a role for inhibition of GJIC during the process of cell transformation 
or tumor formation. For instance, a lack of GJIC between transformed and non-
transformed cells has been reported by several groups on different cell types (7-9). 
The precise mechanisms by which GJIC is regulated in particular by tumor 
promoters are not known. Several groups suggest a role for modulation of gap junction 
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protein (connexin) phosphorylation in the regulation of GJIC (10-13). Indeed, 
hyperphosphorylation as well as hypophosphorylation of gap junction proteins have 
been reported in vitro as well as in vivo, when GJIC was inhibited by tumor promoters 
(4,14,15). The type of effect of a tumor promoter on connexin phosphorylation may 
however be cell type specific, and/or compound specific (16-18). Apart from the level 
of phosphorylation, GJIC inhibition has also been associated with translocation of the 
connexin proteins from the cell-cell contact areas (gap junction plaques) to the cytosol. 
This has been reported for some tumor promoters, like TPA and DDT (3,4,16-18). It 
is however still unclear, how connexin phosphorylation and connexin location are 
associated with modulation of intercellular communication level. If this relationship 
exists, analysis of connexin phosphorylation and connexin localization could be used 
as parameters to predict effects of compounds on GJIC in vivo. 
In mouse keratinocyte cell lines, the presence of the cell adhesion molecule E-
cadherin on the membrane is essential for GJIC (19). In addition, the tumor promoter 
TPA has been shown to decrease cell assembly of primary keratinocytes (17). 
Furthermore, in a recent study, we demonstrated the effects of the tumor promoters 
benzoyl peroxide and TPA on the amount and location of E-cadherin in the mouse 
epidermal cell lines 3PC and CA3/7 (20). This suggests a direct association between 
the level of E-cadherin and inhibition of GJIC. 
Previously, we showed differences in susceptibility for the inhibition of GJIC 
by tumor promoters of cell types representing different stages of tumor formation (21). 
In this study, we tried to get a better insight into factors determining these differences, 
by using histological and molecular analysis of effects by which tumor promoters affect 
GJIC in initiated (3PC) cells, carcinoma (CA3/7) cells and in primary keratinocytes. 
We determined the effects of tumor promoting agents on the phosphorylation- as well 
as the location of the gap junction protein connexin43 in all cell types. Furthermore, 
the effects of tumor promoting agents on the amount and localization of the cell 
adhesion molecule E-cadherin in both cell lines were also studied. 
Results 
First we determined the effect of the selected agents on GJIC in primary mouse 
keratinocytes and in the two mouse epidermal cell lines 3PC and CA3/7 (Table 1). The 
cell line 3PC was overall slightly more sensitive for inhibition of GJIC by tumor 
promoters compared to the cell line CA3/7. The susceptibility of primary keratinocytes 
to inhibition of GJIC compared to the 3PC cell line was variable, depending on the 
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Agent (ug/ml) 
Aroclor 1260 (200) 
DDT (5) 
PB (1000) 
Anisidin (1848) 
Clofibrate (51) 
Ethionin (408) 
Limonene (136) 
NaF (2100) 
TIME 
(min) 
90 
90 
90 
90 
70 
90 
70 
90 
Primary 
Keratinocvtes 
70 
48 
2 * 
55 
nt 
-20* 
12 * 
nt 
3PC 
(initiated cells) 
87 
58 
-5 * 
62 
85 
53 
78 
3 * 
CA3/7 (carcinoma cells) 
60 
32 
4 * 
46 
58 
31 
57 
1 2 * 
Table 1: Percentage of inhibition of GJIC in different cell types after exposure to several tumor promoters 
or the negative control NaF. Negative numbers represent stimulation instead of inhibition of GJIC. The 
number of recipient cells under control conditions (18, 30 and 25 for respectively prim.ker., 3PC and CA3/7 
cells) was not changed by the solvents used. *= not significantly different from control GJIC. 
A 
c an et li cl ar dd c ph NaF 
/ P ' 
\ NP 
B 
c an et ti cl ar dd pb NaF 
m (*<*** mm a A X NP 
c an et li cl pb c ar dd 
^ N P 
Figure 1. Western blot analysis of connexin43 in 3PC cells (A), CA3/7 cells (B) and primary keratinocytes 
(C). c= control (untreated) cells, an= anisidin, et= ethionin, li= limonene, cl= clofibrate, ar= Aroclor 1260, 
dd= DDT, NaF= NaF, and pb= PB. 
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agent used. NaF and PB did not affect GJIC in the cell lines 3PC and CA3/7 and were 
therefore used as negative controls in the molecular and histological assays. 
Directly after exposure of the cells to the tumor promoter, the proteins were 
extracted and Cx43 phosphorylation was analysed by Western analysis. As shown for 
3PC cells in Fig.lA, all selected agents, except for PB, increased the amount of 
phosphorylated Cx43 (an increased intensity of the double phosphorylated band (P2) 
in concurrence with a decreased intensity of the non-phosphorylated (NP) band). PB 
had no effect on Cx43 phosphorylation in this cell line. Except for clofibrate which did 
not change Cx43 phosphorylation, all other agents (including NaF) increased Cx43 
phosphorylation in CA3/7 cells (Fig IB). In Fig 1C is shown, that in primary 
keratinocytes PB, clofibrate, ethionine, limonene and anisidine increased Cx43 
phosphorylation, whereas anisidine also strongly decreased the amount of this gap 
junction protein. Aroclor 1260 and DDT had no effect on Cx43 phosphorylation in 
these cells. In Table 2 the results from the Western analysis are expressed as the ratio 
of the percentage phosphorylated Cx43 and the percentage phosphorylated Cx43 under 
control conditions. These results suggest that a decreased GJIC is associated with 
hyperphosphorylation of Cx43. However, NaF and PB treatments, which did not affect 
GJIC, also caused hyperphosphorylation of Cx43 in the different cell types. 
(% phosphorylated Cx43) / (% phosphorylated Cx43 control) 
Agent 
DDT 
Aroclor 1260 
o-Anisidin 
Clofibrate 
L-Ethionine 
d-Limonene 
Phenobarbital 
NaF 
3PC 
1.75 
1.46 
2.14 
2.04 
1.83 
2.07 
1.24 
1.79 
CA3/7 
1.55 
1.54 
1.25 
1.18 
1.06 
0.79 
1.61 
1.48 
Prim. Keratinocytes 
1.06 
1.06 
1.55 
1.52 
1.38 
1.42 
1.14 
nt 
Table 2: The ratio of the percentage phosphorylated Cx43 in exposed cells and the percentage 
phosphorylated Cx43 under control conditions. The control % of phosphorylated Cx43 were respectively 
38%; 33%, and 31% for 3PC cells, CA3/7 cells, and primary keratinocytes. nt = not tested. 
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A 
Figure 2. Immunostaining of Cx43 in 3PC cells (A), CA3/7 cells (B), and primary keratinocytes (C). Picture 
1: control cells, same staining was found with NaF and PB treated cells. Picture 2: slightly decreased 
membrane staining of Cx43. Picture 3: strongly decreased staining of Cx43 on the membrane, in concurrence 
with increased cytosolic staining of Cx43. Picture 4: Strongly decreased Cx43 immunostaining, without 
increased cytosolic Cx43 staining. Narrow arrow heads mark examples of staining on the membrane between 
cells, broad arrow heads mark examples of cytosolic staining in cells. Bar = 20 urn in every serie of pictures. 
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We also examined the effect of these tumor promoters on the location of Cx43 
in the cells. As shown in Fig. 2A, all tumor promoters with GJIC inhibiting capacity 
caused a decreased immunostaining of Cx43 on the cell membranes of 3PC cells. 
Limonene slightly decreased the membrane immunostaining of Cx43 in 3PC cells, as 
represented by Fig.2A2. Aroclor 1260, DDT and anisidine caused a slight change in 
immunofluorescence from the membrane to the cytosol (Fig.2A3), whereas clofibrate 
and ethionin strongly decreased the intensity of Cx43 immunostaining in 3PC cells. In 
the cell line CA3/7 (Fig 2B) both Aroclorl260 and clofibrate caused an increase of 
immunofluorescence in the cytosol in concurrence with a decreased 
immunofluorescence on the membrane (Fig.2B3), whereas the other agents strongly 
(limonene, Fig.2B4) or moderately (DDT, anisidine, ethionin, Fig.2B2) decreased the 
membrane Cx43 staining. Both NaF and PB had no effect on levels of Cx43 staining 
in both cell lines 3PC and CA3/7. In primary keratinocytes (Fig.2C), only Aroclor 
1260 and DDT caused a changed immunofluorescence from the membrane to the 
cytosol (Fig.2C3). In these cells, ethionin, limonene and anisidine slightly decreased 
the membrane bound immunofluorescence (Fig.2C2), whereas clofibrate strongly 
decreased the Cx43 immunostaining (Fig.2C4). These results suggest that, besides 
phosphorylation of the gap junction protein, also the localization of this protein can be 
changed by tumor promoters. 
Because, in mouse epidermal cells, GJIC was shown to be also regulated by the 
cell adhesion molecule E-cadherin (Jongen et al., 1991), and the tumor promoters TPA 
and benzoyl peroxide have been shown to decrease the amount of E-cadherin and/or 
the localization of this molecule (Jansen et al, submitted), we studied the effects of the 
selected agents on the quantity and localization of E-cadherin in both cell lines. Figure 
3 shows that the amount of E-cadherin was not obviously decreased in the cell line 
CA3/7 when the cells were treated with the selected agents. The same results were 
obtained with the cell line 3PC (data not shown). 
an et li cl dd ar pb NaF 
l 
- E-cadherin 
Figure 3. Western blot analysis of E-cadherin in CA3/7 cells, c = control (untreated) cells, an = anisidin, 
et = ethionin, li=limonene, cl = clofibrate, dd = DDT, ar = Aroclor 1260, and PB = phenobarbital. 
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Although the quantity of E-cadherin was not changed, its functionality (i.e.localization) 
may be affected by tumor promoters. This is shown in Fig. 4, in which E-cadherin 
immunostaining results of both cell lines are presented. In 3PC cells, clofibrate and 
limonene strongly decreased the membrane-bound immunofluorescence in concurrence 
with an increased staining around the nucleus (Fig.4A3). Aroclor 1260, DDT, 
ethionine, and anisidine caused translocation of E-cadherin from the membrane to the 
B 
Figure 4. Immunostaining of E-cadherin in 3PC cells (A) and CA3/7 cells (B). Picture 1: control cells, same 
staining was found with NaF and PB treated cells. Picture 2: slightly decreased membrane staining of E-
cadherin with (3PC) or without (CA3/7) increased cytosolic staining of E-cadherin. Picture 3: strongly 
decreased staining of E-cadherin on the membrane, without increased cytosolic staining. Picture 4: Very 
strong decrease of E-cadherin immunostaining. Narrow arrow heads mark examples of staining on the 
membrane between cells, broad arrow heads mark examples of cytosolic staining in cells. Bar = 20 urn in 
every serie of pictures. 
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cytosol to a lesser extent (Fig.4A2). In CA3/7 cells anisidin, ethionin and limonene 
weakly decreased E-cadherin bound membrane immunofluorescence, whereas DDT had 
a much stronger effect (Fig.4B2 resp. 4B4). Clofibrate and aroclor 1260 had an 
intermediate effect in these cells (Fig.4B3). In CA3/7 cells no cytosolic staining was 
observed. The negative controls, NaF and PB, did not affect E-cadherin 
immunostaining in the two cell lines. 
Discussion 
Inhibition of intercellular communication via gap junctions by tumor promoters has 
been shown both in vivo (4) and in vitro (3,6) to be an important event in the process 
of tumor formation. Since several tumor promoters are known to decrease GJIC in 
association with a changed level of phosphorylation of gap junction proteins 
(connexins) (14,15), we studied the effects of several agents on GJIC and on the 
phosphorylation of the major connexin expressed in the mouse epidermal cells we used 
(Cx43) (21). Previously, it was shown that differences occur in the susceptibility of 
cells for inhibition of GJIC by tumor promoters (22). Therefore, we compared the 
effects of exposure to tumor promoters on Cx43 phosphorylation in these cells. Fig 1 
shows that most agents with GJIC inhibiting capacity caused an increase in 
phosphorylated Cx43 protein in concurrence with a decreased intensity of the non-
phosphorylated Cx43 band (NP), in all three cell types. However, an increase in Cx43 
phosphorylation is not strictly associated with a decreased GJIC, since agents with no 
effect on GJIC could also increase Cx43 phosphorylation (ethionine and limonene in 
Fig 1A, NaF in Fig IB and 1C, PB in Fig 1A and 1C). Furthermore, GJIC can be 
affected without a change in Cx43-phosphorylation as shown by DDT and Aroclor 
1260 in primary keratinocytes, as well as clofibrate in CA3/7 cells. Recently we found 
that benzoyl peroxide (BoP) treatment caused dephosphorylation of Cx43 protein in 
primary keratinocytes and in 3PC cells, whereas Cx43 was more phosphorylated in 
BoP treated CA3/7 cells (20). In addition TPA hyperphosphorylated Cx43 in all three 
cell types. All these results suggest that within one cell type, inhibition of GJIC can 
not be tightly associated with one explicit effect on Cx43 phosphorylation. These 
results also show that the effect of tumor promoters on Cx43 phosphorylation may 
vary, depending on the cell type used. This is consistent with the reports of other 
groups, that TPA has differing effects on Cx43 phosphorylation, depending on the cell 
type used (4,16-18). 
GJIC could also be inhibited by changes in the localization of connexins. As 
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shown in Fig.2, all tumor promoters decreased the intensity of immunocytochemical 
Cx43 staining on the cell membrane. The effects of the agents used were not consistent 
in all three cell types. Exposure to some agents caused a decrease in membrane-
associated Cx43-linked immunostaining with a concurrent increase in cytosolic 
staining, whereas with other agents only membrane associated staining was decreased. 
A previous study with mouse epidermal cell lines showed that inhibition of protein 
synthesis by cyclohexidine did not affect the extracellular calcium mediated increase 
of GJIC (19). This suggests that the turnover of Cx43 in these cells is not as high as 
shown for Cx26 in hepatocytes (23) and for Cx43 in cardiomyocytes (24). Because the 
total amount of Cx43 protein per mg of total protein was not affected by exposure of 
the cells to the tumor promoters (Fig 1), the decreased intensity of membrane Cx43 
immunofluorescence, without an increased cytosolic staining, suggests a dispersion of 
the Cx43 protein from the plaques over the membrane, resulting in a fluorescent 
intensity below the visual detection limit. 
In a former study we reported a decreased level of Cx43 immunostaining after 
TPA treatment of the same cells as used here (20). BoP changed the location of the 
Cx43-linked immunostaining. Several other reports showed a decreased or translocated 
Cx43 after exposure of cells to PCB (4), TPA (25-27), PB (4) and DDT (18,25), 
although these changes do not always occur (16,18). These results, together with the 
findings presented in this paper, show that Cx43 phosphorylation, as well as the 
cytoplasmic location of Cx43 are both dependent on the cell type and on the compound 
used. The effects on Cx43 immunostaining could not be linked with effects on Cx43 
phosphorylation as tested by Western analysis, nor with effects on GJIC (as shown for 
3PC cells in Table 3). It should be noted however, that all agents which affected GJIC, 
changed the location of Cx43 as tested by immunofluorescence. 
Because E-cadherin has been shown to regulate GJIC in mouse keratinocytes 
(19), and E-cadherin amount and/or localization of E-cadherin can be changed by 
exposure of mouse keratinocytes to tumor promoters, we studied the effects of the 
selected agents on the amount and localization of E-cadherin in the two cell lines 3PC 
and CA3/7. All selected compounds did not affect the amount of E-cadherin as 
determined by Western analysis (Fig 3.). This suggests that the decreased amount of 
this cell adhesion molecule after treatment of the cells with BoP is an effect specific 
for this compound. 
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Agent (|ig/ml) 
Aroclor 1260 (200) 
DDT (5) 
PB (1000) 
Anisidin (1848) 
Clofibrate (51) 
Ethionin (408) 
Limonene (136) 
NaF (2100) 
TPA (2)+ 
BoP (40)+ 
Cx43 $ 
phosphorylation 
T 
T 
= 
T 
t 
t 
r 
T 
t 
1 
Cx43* 
localization 
—>c 
->c 
= 
->c 
u 
II 
1 
= 
1 
I I 
GJIC* 
u 
I I 
= 
I I 
I I 
I I 
I I 
= 
1 
I I 
E-cadherin * 
localization 
->c 
—>c 
= 
—>c 
I I 
->c 
u 
= 
-»c 
>1"4'N' 
Table 3: Summary of the effects of the tumor promoters we tested on GJIC, on Cx43 phosphorylation and 
on immunostaining of Cx43 and E-cadherin in 3PC cells. $: symbols (I, t , =) represent a decrease, an 
increase or an unchanged phosphorylation respectively. *: symbols represent a slightly (I), a strongly (II) 
or unchanged (=) staining, or a translocated staining to the cytosol (—>c). A: symbols represent level of 
inhibition of GJIC = (0-10%), I (10-50%) and I I (50-100%). +: results from Jansen et al, submitted. 
The change in localization of E-cadherin caused by the selected tumor 
promoting agents, as shown in Fig.4, is a further support of the finding that tumor 
promoting agents can affect the function of this cell adhesion molecule (20). As for 
Cx43 immonostaining, no association can be found between the degree of GJIC 
inhibition and the type of changed E-cadherin immunostaining (Table 3). The found 
results were however specific for the tested compounds with GJIC inhibiting capacity, 
because NaF and PB (only decreasing GJIC in 3PC cells after metabolic activation, 
(21)) did not affect E-cadherin localization in both cell lines. 
By which mechanism tumor promoters can change the localization of both 
connexin43 and E-cadherin in these cells is unknown. (De)Activation of protein kinases 
could play a role in these mechanisms, as well in the mechanisms of GJIC inhibition, 
because the association between the activation of several protein kinases and the 
inhibition of GJIC, as well as the translocation of connexin43 has been observed 
(16,18,27-29). 6-catenin, a E-cadherin binding molecule with E-cadherin regulating 
capacity (30,31), has also been shown to loose functioning when phosphorylated on 
tyrosine (32,33). Furthermore it would be interesting to study time related tumor 
promoter induced changes in E-cadherin immunofluorescence and Cx43 immuno-
fluorescence. This could give more information about the possibility that changes in 
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E-cadherin immunofluorescence are proceeding changes in Cx43 immunofluorescence. 
If this is the case, it would be in agreement with the findings that E-cadherin can 
regulate GJIC in mouse epidermal cells (19). 
To determine whether any relationship exists between GJIC, Cx43 
phosphorylation and Cx43 localization, the phosphorylation of Cx43 should be studied 
in more detail. For instance oncogene activation was shown to lead to inhibition of 
GJIC in concurrence with phosphorylation of Cx43 on tyrosine residues, and exposure 
of rat liver epithelial cells to epidermal growth factor induced inhibition of GJIC and 
Cx43 phosphorylation on serine residues (34,35). Phosphorylation on specific amino 
acid residues of Cx43 might give more information about the specificity of tumor 
promoter-induced Cx43 phosphorylation, and its relation with GJIC inhibition. 
Overall these results show that the level of Cx43 protein phosphorylation is not 
predictive for the effect on GJIC. Furthermore, an effect on GJIC is associated with 
a change in Cx43- and E-cadherin linked immunostaining, although the effect on the 
immunostaining of these proteins is agent- as well as cell type specific. 
Acknowledgements 
Part of the work presented in this paper was carried out at the Unit of Multistage 
Carcinogenesis of the International Agency for Research on Cancer (IARC), Lyon, 
France. The authors thank Dr.H.Yamasaki (chief of the Unit) for discussions, C.Piccoli 
for practical assistance, G.Mollon for photographic work, and T.de Vrije for critical 
reading the manuscript. This work was partially financed by a grant from the 
commission of the European Communities in the program of Science and Technology 
for Environmental Protection (STEP) Nr. 106837. L.A.M.Jansen was a recipient of a 
short-visiting grant from the European Science Foundation in The program of 
Toxicology. 
References 
1. Boutwell,R.K. (1974) The function and mechanism of promoters of carcinogenesis. CRC 
Crit.Rev.Toxicol., 2, 419-443. 
2. Pitot,H.C. and Sirica.AE. (1980) The stages of initiation and promotion in hepatocarcinogenesis. 
Biochim.Biophys.Acta, 605, 191-215. 
3. Mesnil,M., Asamoto,M., Piccoli,C, and Yamasaki,H. (1994) Possible molecular mechanism of loss 
of homologous and heterologous gap junctional intercellular communication in rat liver epithelial 
cell lines. Cell Adhesion Comm., 2, 377-384. 
100 
Tumor promoters affect Cx43 and E-cadherin location 
4. Krutovskikh.V.A., Mesnil,M., Mazzoleni,G., and Yamasaki.H. (1995) Inhibition of rat liver gap 
junctional intercellular communication by tumor-promoting agents in vivo. Lab.Invest., 72,571-577. 
5. TroskoJ.E. and Chang,C.C. (1988) In: Carcinogen risk assessment: new directions in the qualitative 
and quantitative aspects. Hart.R.W. and Hoerger,F.D. (eds.), Cold Spring Harbor laboratory, Cold 
Spring Harbor, NY, 139-170. 
6. Budunova.I.V. and Williams,G.M. (1994) Cell culture assays for chemicals with tumor-promoting 
or tumor-inhibiting activity based on the modulation of intercellular communication. Cell 
Biol.Toxicol., 10,71-116. 
7. BertramJ.S. and Faletto.M.B. (1985) Requirements for and kinetics of growth arrest of neoplastic 
cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-
phosphodiesterase. Cancer Res., 45, 1946-1952. 
8. Mesnil,M. and Yamasaki,H. (1988) Selective gap junctional communication capacity of transformed 
and non-transformed rat liver epithelial cell lines. Carcinogenesis, 9, 1499-1502. 
9. Yamasaki,H., Hollstein,M., Mesnil.M., Martel.N. and Aguelon,A.-M. (1987) Selective lack of 
intercellular communication between transformed and nontransformed cells as a common property 
of chemical and oncogene transformation of BALB/c 3T3 cells. Cancer Res., 47, 5658-5664. 
10. Weiner,E.C. and Loewenstein,W.R. (1983) Correction of cell-to-cell communication defect by 
introduction of a protein kinase into mutant cells. Nature, 305, 433-435. 
11. Gainer,H.St.C. and Murray,A.W. (1985) Diacylglycerol inhibits gap junctional communication in 
cultured epidermal cells: evidence for a role of protein kinase C. Biochem.Biophys.Res.Comm., 126, 
1109-1113. 
12. SaezJ.C, Spray,D.C, Nairn,A.C, Hertzberg.E., Greengard,P., and Bennett,M.V.L. (1986) cAMP 
increases junctional conductance and stimulates phosphorylation of the 27-kDa principal gap 
junction polypeptide. Proc.Natl.Acad.Sci.USA, 83, 2473-2477. 
13. Filson.A.J., Azarnia,R., Beyer,E.C. Loewenstein,W.R., and Brugge.J.S. (1990) Tyrosine 
phosphorylation of a gap junction protein correlates with inhibition of a cell-to-cell communication. 
Cell Growth & Differentiation, 1, 661-668. 
14. Oh,S.Y., Madhucar,B.V., and TroskoJ.E. (1988) Inhibition of gap junctional blockage by parmitoyl 
carnitine and TMB-8 in a rat liver epithelial cell line. Carcinogenesis, 9, 135-139. 
15. MatesicJD.F., Rupp,H.L. Bonney,WJ. Ruch,R.J., and TroskoJ.E. (1994) Changes in gap-junction 
permeability, phosphorylation, and number mediated by phorbol ester and non-phorbol-ester tumor 
promoters in rat liver epithelial cells. Mol.Carcinog., 10, 226-236. 
16. Berthoud,V.M, Ledbetter.M.L.S. Hertzberg,E.L., and SaezJ.C. (1992) Connexin43 in MDCK cells: 
regulation by a tumor-promoting phorbol ester and Ca2+. Eur.J.Cell Biol., 57, 40-50. 
17. BrissetteJ.L., Kumar,N.M. Gilula,N.B., and Dotto.G.P. (1991) The tumor promoter 12-o-
decanoylphorbol-13-acetate and the ras oncogene modulate expression and phosphorylation of gap 
junction proteins. Mol.Cell.Biol., 11, 5364-5371. 
18. Rivedal.E., Yamasaki,H. and Sanner,T. (1994) Inhibition of gap junctional intercellular 
communication in Syrian hamster embryo cells by TPA, retinoic acid and DDT. Carcinogenesis, 
15, 689-694. 
19. Jongen.W.M.F., Fitzgerald,DJ., Asamoto.M., Piccoli.C, Slaga,T.J., Gros.D., Takeichi.M., and 
Yamasaki,H. (1991) Regulation of connexin-43 mediated gap juuctional intercellular communication 
101 
Chapter 7 
by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J.Cell Biol., 14, 545-555. 
20. Jansen.L.A.M., Mesnil,M., and Jongen.W.M.F. (1996) Inhibition of gap junctional intercellular 
communication and derealization of the cell adhesion molecule E-cadherin by tumor promoters. 
Carcinogenesis, in press. 
21. Jansen, L.A.M. and W.M.F. Jongen (1995) The use of initiated cells as a test system for detection 
of inhibitors of GJIC. Carcinogenesis, 17, 333-339. 
22. Bombick,D.W. (1990) Gap junctional communication in various cell types after chemical exposure. 
In Vitro Toxicol., 3, 27-39. 
23. Traub.O., Look,J., Paul,D., and Willecke,K. (1987) Cyclic adenosine monophosphate stimulates 
biosynthesis and phosphorylation of the 26 kDa gap junction protein in cultured mouse hepatocytes. 
EurJ.Cell Biol., 43, 48-54. 
24. Laird,D.W., Puranam.K.L., and Revel,J.-P. (1991) Turnover and phosphorylation dynamics of 
connexin43 gap junction protein in cultured cardiac myocytes. Biochem.J., 273, 67-72. 
25. Budunova,I.V., Williams,G.M., and Spray.D.C. (1993) Effect of tumor promoting stimuli on gap 
junctional permeability and connexin43 expression in ARL18 rat liver cell line. Arch.Toxicol., 67, 
565-572. 
26. Enemoto.T. and Asano,Y. (1994) Deficiency of tyrosine phosphorylation in a Balb/c 3T3 cell 
variant hypersensitive to phorbol ester-induced cell transformation. Carcinogenesis, 15, 1093-1097. 
27. Kenne,K., Fransson-Steen.R., Honkasalo,S., and Warngard.L. (1994) Two inhibitors of gap 
junctional intercellular communication, TPA and endosulfan: different effects on phosphorylation 
of connexin 43 in the rat liver epithelial cell line, IAR 20. Carcinogenesis, 15, 1161-1165. 
28. Klaunig,J.E. and Ruch,RJ. (1987) Role of cyclic AMP in the inhibition of mouse hepatocyte 
intercellular communication by liver tumor promoters. Toxic.Appl.Pharmac, 91, 159-170. 
29. Moser,G.J. and Smart,R.C. (1989) Hepatic tumor-promoting chlorinated hydrocarbons stimulate 
protein kinase C activity. Carcinogenesis, 10, 851-856. 
30. Gumbiner,B.M. and McCrea,P.D. (1993) Catenins as mediators of the cytoplasmic functions of 
cadherins. J. Cell Sc , suppl 17, 155-158. 
31. Hinck,L., Nathke,I.S. PapkoffJ., and Nelson,W.J. (1994) 6-catenin: a common target for the 
regulation of cell adhesion by Wnt-1 and Src signaling pathways. Trends Biochem.Sc, 19,538-542. 
32. BehrensJ., Vakaet,L. Friis.R. Winterhager,E., Roy.R.V. Mareel,M.M., and Birchmeier.W. (1993) 
Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation 
of the E-cadherin/6-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. 
J.Cell Sc , 120, 757-766. 
33. Matsuyoshi,N., Hamaguchi.M., Taniguchi,S., Nagafuchi,A., Tsukita.S., and Takeichi,M. 
(1992) Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation 
in metastatic fibroblasts. J.Cell Biol., 118, 703-714. 
34. Crow,D.S., Beyer,E.C. Paul,D.L., Kobe,S.S., and Lau,A.F. (1990) Phosphorylation of connexin43 
gap junction protein in uninfected and Rous Sarcoma Virus-transformed mammalian fibroblasts. 
Mol.Cell.Biol., 10, 1754-1763. 
35. Lau.A.F., Kanemitsu,M.Y., Kurata,W.E., Danesh,S., and Boynton,A.L. (1992) Epidermal growth 
factor disrupts gap-junctional communication and induces phosphorylation of connexin43 on serine. 
Mol.Biol.Cell, 3, 865-874. 
102 
Chapter 8 
The role of calcium in tumor promoter-mediated 
inhibition of gap junctional intercellular communication 
This paper is based on the paper: 
L.A.M.Jansen, T.de Vrije, J.H.Koeman, and W.M.F.Jongen (1996) The role of calcium in tumor promoter-
mediated inhibition of gap junctional intercellular communication. Submitted to Environmental Toxicology 
and Pharmacology. 
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Abstract 
The effect of several tumor promoters (12-<9-tetradecanoyl-phorbol-13-acetate (TPA); 
l,r-(2,2,2-trichloroethylidene)bis[4-chlorobenzene] (DDT); Aroclorl260; L-ethionine; 
d-limonene; o-anisidine, and clofibrate) on the inhibition of gap junctional intercellular 
communication (GJIC) and intracellular calcium concentration ([Ca2+];) were studied 
in a cell line consisting of initiated cells (3PC) and a carcinoma-derived cell line 
(CA3/7). In addition, the effect of different extracellular calcium concentrations 
([Ca2+]e) on the effects of tumor promoters on both GJIC and [Ca2+]; were studied, 
using the same tumor promoters. Agents with GJIC inhibiting capacity also increased 
[Ca2+]j in both cell lines. However, the increase of [Ca2+]; did not (always) precede 
GJIC inhibition, suggesting that the effect of tumor promoters on GJIC is not directly 
related to their effect on [Ca2+](. This is supported by the finding that tumor promoter-
mediated inhibition of GJIC in the 3PC cell line did not differ between low (0.05 mM) 
and high (1.20 mM) Ca2+e conditions, while differing effects on [Ca2+]; were found. 
The differences in susceptibility between the two cell lines for inhibition of 
GJIC by tumor promoters could not be explained by the effects of the used agents on 
the [Ca2+]j in both cell types. These results suggest that tumor promoters can inhibit 
GJIC and change [Ca2+]j, but that there is no direct relationship between these two 
processes. 
Introduction 
It has been hypothesised that in the multistep process of tumor formation, a decreased 
gap junctional intercellular communication (GJIC) could give genetically altered (initia-
ted) cells the possibility for clonal expansion (1,2). Gap junctions are intercellular 
channels, permitting small metabolites, ions and second messengers to pass to 
neighbouring cells. The channels are made of juxtaposed connexons crossing the 
membrane of two adjacent cells. Each connexon is formed by six protein subunits 
called connexins (3,4). How the functioning of connexons is regulated is still unknown 
but several groups have suggested that changes in the intracellular calcium 
concentration ([Ca2+];) are involved in the regulation of GJIC (5-7). Furthermore two 
tumor promoters which decreased GJIC, raised [Ca2+]j (8). This changed [Ca2+]j could 
(de)activate GJIC modulating molecules or enzymes, like calmodulin or 
Ca2+/calmodulin dependent protein kinases. Recently we showed the involvement of 
both [Ca2+]i and calmodulin (CaM) in the regulation of GJIC in a cell line consisting 
of initiated cells (3PC) and a carcinoma derived cell line (CA3/7) (Jansen et al., 
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submitted). In 3PC cells under low extracellular calcium (Ca2+e) conditions (0.05 mM), 
GJIC was inhibited by the Ca2+( chelator EGTA-AM, while an increase of [Ca2+]j did 
not change the high level of GJIC. In CA3/7 cells cultured under low Ca2+e conditions, 
the low GJIC level could be increased by raising [Ca2+];. Under high [Ca2+]e conditions 
(1.2 mM), both cell types had a high GJIC level, which remained unaffected while 
[Ca2+]i was increased by calcium ionophores or decreased by EGTA-AM. If calcium 
is to play a role in the tumor promoter-mediated inhibition of GJIC, these results 
suggest an decreased [Ca2+]; as a results of exposure to tumor promoters. However, 
since the [Ca2+]e is 500 to 104 times higher (for low and high Ca2+ medium) then 
[Ca2+];, a decrease of [Ca2+]j is most unlikely to occur, but a significant increase might 
be expected as a result of effects of tumor promoters on calcium transport over 
(plasma) membranes. That would agree with the results of other groups, describing an 
inhibition of GJIC when [Ca2+]j was increased (7,9). 
We recently demonstrated that both cell lines can be used for the detection of 
GJIC-inhibiting agents (10). To get more insight in the mechanism by which tumor 
promoters inhibit GJIC, we determined the effects of several tumor promoters on GJIC 
and on [Ca2+]j in 3PC cells. In addition, the possible influence of [Ca2+]e on the tumor 
promoter-mediated inhibition of GJIC and change of [Ca2+]j were studied. Because the 
sensitivity of CA3/7 cells for the inhibition of GJIC by tumor promoters is different 
compared to 3PC cells (10), we also studied the effects of some tumor promoters on 
GJIC and the [Ca2+]j in CA3/7 cells. 
Results 
Several compounds with a GJIC inhibiting capacity in a broad spectrum of cell types 
(11) were used. The GJIC level of 3PC cells under low (0.05 mM) Ca2+e conditions 
(mean = 30 communicating cells) remained unchanged during 90 minutes under these 
conditions, and was not changed either under high (1.20 mM) or Ca2+e-free conditions 
(data not shown). As shown in Figure 1A, TPA-mediated inhibition of GJIC in 3PC 
cells was comparable under low compared to high Ca2+e conditions. In Ca2+-free PBS, 
the inhibition of GJIC was comparable to that under the other two Ca2+e conditions up 
to 45 minutes of exposure, and significantly stronger after 90 minutes of exposure. 
Under Ca2+e-free conditions, TPA exposure did not affect the intracellular calcium 
concentration ([Ca2+]j) (Fig.IB). TPA exposure under low Ca2+e conditions increased 
[Ca2+]j, whereas under high Ca2+e conditions, [Ca2+]j was strongly increased. The 
polychlorobiphenyl mixture Aroclorl260 (200 ug/ml) decreased the GJIC level in 3PC 
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Figure 1: The effect of several agents on GJIC (A,C,E,G) and [Ca2+]j (B,D,F,H) in 3PC cells under Ca2+e-free 
conditions (triangular symbols); low Ca2+C conditions (round symbols), and high Ca2+e conditions (square 
symbols). After determining the control level of GJIC (=100%) and [Ca2+]h the cells were exposed to 4 
ug/ml TPA (A,B); 200 ug/ml Aroclorl260 (C,D); 5 ug/ml DDT (E,F); or 51 ug/ml clofibrate (G,H), after 
which the effects on GJIC or [Ca2+]j were studied. 
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cells comparably under low Ca2+e and high Ca2+e conditions (Fig.lC). In the absence 
of Ca2+e however, the GJIC level was less affected by exposure of the cells to 
Aroclorl260. Whereas under high Ca2+e conditions, [Ca2+]; was not significantly 
changed during exposure, Aroclorl260 increased [Ca2+]; in 3PC cells in Ca2+-free 
medium and in low Ca2+ medium (Fig. ID). The DDT (5 ug/ml)-mediated inhibition of 
GJIC was comparable under low and high Ca2+e conditions, while in Ca2+-free PBS the 
GJIC level was decreased stronger (Fig. IE). DDT induced only under low Ca2+e 
conditions a temporally significant increase of [Ca2+]j, while under the high Ca2+e 
conditions [Ca2+]; remained unchanged, and under Ca2+e-free conditions, [Ca2+]j was 
decreased (Fig.lF). Under all three Ca2+e conditions, the clofibrate (51 ug/ml)-induced 
inhibition of GJIC in 3PC cells was in the same order of magnitude (Fig.lG). The 
effects of clofibrate on [Ca2+]; was however dependent on the Ca2+e conditions. 
Exposure of the cells under a higher Ca2+e condition resulted in a stronger increase of 
[Ca2+]f (Fig.lH). The GJIC inhibiting capacity of anisidin, ethionine and limonene were 
recently shown in these cells and in primary keratinocytes (10). The effects of these 
agents on GJIC and [Ca2+]; were studied in 3PC cells under low Ca2+e conditions 
(Fig.2). Both ethionine (408 pg/ml) and limonene (136 ug/ml) strongly decreased the 
GJIC level within 15 minutes of exposure (Fig.2A). Upon longer exposure times, the 
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Figure 2: The effect of 1848 ug/ml anisidine (triangular symbols); 408 ug/ml ethionine (round symbols) or 
136 ug/ml limonene (square symbols) on GJIC (A) and [Ca2+]j (B) in 3PC cells under low Ca2+e conditions. 
The effects were studied as described in Fig.l for other compounds. 
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GJIC level was further decreased in limonene treated cells, whereas in ethionine-treated 
cells the GJIC level remained the same. Exposure of the cells to anisidine (1848 |ig/ml) 
resulted in a gradual decrease of GJIC after 70 and 90 minutes of exposures to a level 
comparable to limonene- and ethionine-treated cells. Exposure to all 3 compounds for 
20 minutes resulted in an almost doubled [Ca2+]i (Fig.2B). After 20 minutes of 
exposure, [Ca2+]( raised further in anisidine- and ethionine-treated cells. In limonene-
exposed cells, the [Ca2+]; returned to the control level after 40 minutes of exposure. 
Then [Ca2+]> raised again, after which [Ca2+]; returned to the control level. 
The carcinoma derived cell line (CA3/7) has a low GJIC level under low Ca2+e 
conditions compared to 3PC cells (12). When the [Ca2+]e was increased to 1.20 mM, 
the GJIC level of CA3/7 cells raised to a level comparable to 3PC cells. The effect of 
several of the selected compounds on GJIC and [Ca2+]; in CA3/7 cells were studied 
under high Ca2+e conditions, because of the high GJIC level of these cells under these 
conditions. Because the [Ca2+]e-mediated increase of GJIC in CA3/7 cells could be due 
to a Ca2+e-mediated increase of [Ca2+]; (Jansen et al., submitted), the effects of a tumor 
promoter on GJIC and on [Ca2+]j were also studied under low Ca2+e conditions if a 
tumor promoter increased [Ca2+]j under high Ca2+e conditions. 
As shown in Fig.3A, 2 ug/ml TPA and 200 ug/ml Aroclorl260 decreased the 
GJIC level in CA3/7 cells to the same degree. Under high Ca2+e conditions in CA3/7 
cells, TPA induced a transient [Ca2+]j increases (Fig.3B), while under low Ca2+e 
conditions [Ca2+]j remained unchanged after TPA exposure (data not shown). Under 
high Ca2+e conditions, Aroclorl260 increased [Ca2+]j significantly in CA3/7 cells from 
30 minutes of exposure. Under low Ca2+e conditions, Aroclorl260 induced one [Ca2+]j 
peak after 40 minutes and [Ca2+]j was increased after 90 minutes of exposure. DDT (5 
ug/ml) inhibited GJIC in CA3/7 cells up to 25% after 90 minutes of exposure (Fig.3C). 
In addition, DDT exposure of CA3/7 cells under high Ca2+e conditions increased [Ca2+]i 
(Fig.3D), whereas under low Ca2+e conditions [Ca2+]; remained unchanged (data not 
shown). GJIC between CA3/7 cells was stronger affected by 51 ug/ml clofibrate under 
high Ca2+e conditions compared to the effect of DDT. Clofibrate strongly increased 
[Ca2+]j after 70 minutes of exposure of CA3/7 cells under low and high Ca2+e 
conditions. Because the Ca2+e-mediated increase of the GJIC level in CA3/7 cells could 
due to a [Ca2+]e-induced increase of [Ca2+]j (Jansen et al., submitted), we studied the 
effect of a clofibrate-induced increase of [Ca2+]j on the GJIC level in CA3/7 cells under 
those conditions. The percentage of remaining GJIC in CA3/7 cells under low Ca2+e 
conditions was however decreased by clofibrate to a comparable level as under high 
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Ca2+e conditions (Fig.3C). 
A ,; 
Figure 3: The effect of of several agents on GJIC (A,C) and [Ca2+]; (B,D) in CA3/7 cells under low Ca2+e 
conditions (round symbols), and high Ca2te conditions (square or triangular symbols). After determining the 
control level of GJIC (=100%) and [Ca2+]„ the cells were exposed to 4 ug/ml TPA (A,B; square symbols); 
200 ug/ml Aroclorl260 (A,B; round or triangular symbols); 5 ug/ml DDT (C,D; square symbols); or 51 
ug/ml clofibrate (C,D; round or triangular symbols), after which the effects on GJIC or [Ca2+]; were studied. 
Discussion 
In this study we demonstrated that, in addition to an inhibitory effect on gap junctional 
intercellular communication, agents with tumor promoter capacity can also change 
intracellular Ca2+ levels. One of the most widely used tumor promoters, TPA, inhibited 
GJIC in 3PC cells to the same extent as in CA3/7 cells. In addition, TPA induced 
(transient) increases of [Ca2+]j in both cell lines. The TPA-induced increased of [Ca2+]; 
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in both cell types appeared to be dependent on the [Ca2+]e. Under conditions in which 
the [Ca2+]e was higher, the [Ca2+]i increase was also higher. Several other groups have 
reported an effect of TPA on [Ca2+]j. In MDCK cells the [Ca2^ was doubled within 
30 minutes of exposure of the cells to TPA-containing medium under high Ca2+e 
conditions (13). This [Ca2+]j increase is comparable with the effect of TPA found in 
both CA3/7 cells and 3PC cells under high Ca2+e conditions. In V79 cells TPA was 
shown to increase the Ca2+ influx, and to inhibit its efflux (8). These results, together 
with our results presented here, demonstrate that TPA can increase [Ca2+]j in various 
cell types. The induced [Ca2+]j increase may be due to an increase of the activity of 
protein kinase C (PKC) by TPA (14). Indeed, PKC has been shown to play a role in 
the regulation of [Ca2+]j in several cell types (6,15,16), which may be due to an effect 
on the Ca2+-ATPase activity (17). However, the TPA-induced [Ca2+]i change might also 
be the result of other non PKC-dependent mechanisms (8). 
Aroclorl260-mediated inhibition of GJIC was significantly stronger in 3PC cells 
compared to CA3/7 cells after 70 minutes of exposure. It is interesting to note that in 
Ca2+-free medium, the inhibition of GJIC in 3PC cells is much lower compared to the 
inhibition of GJIC in medium containing low or high [Ca2+]. This suggests a role for 
Ca2+e in the Aroclorl260-mediated inhibition of GJIC. The effects on [Ca2+]j in CA3/7 
cells are comparable to those observed in 3PC under the same Ca2+e conditions. 
Aroclorl260 induced a (transient) [Ca2+]j increase under Ca2+e-free (3PC) and under low 
Ca2+e conditions (CA3/7 and 3PC), but not under high Ca2+e conditions in both cell 
types. GJIC was however strongly decreased in both cell lines under high Ca2+e 
conditions, suggesting that the role of [Ca2+]j in the Aroclorl260-mediated inhibition 
of GJIC is limited. 
In contrast to the stimulating role of Ca2+e in the inhibition of GJIC in 3PC cells 
by Aroclorl260, DDT inhibited GJIC stronger in the same cell type under Ca2+e-free 
conditions compared to conditions in the presence of Ca2+e. These results suggests that 
different mechanisms are involved in the inhibition of GJIC by these two chlorinated 
hydrocarbons. Exposure of 3PC cells to DDT under Ca2+e-free conditions induced a 
strong inhibition of GJIC in concurrence with a decreased [Ca2+]j. DDT increased 
[Ca2+]j only transiently under low Ca2+e conditions in 3PC cells, and under high Ca2+e 
conditions in CA3/7 cells. The inhibition of GJIC was significantly less in CA3/7 cells 
compared to 3PC cells. These differences can be explained by the effects of DDT on 
the increase of [Ca2+]j under high Ca2+e conditions, which were stronger in CA3/7 cells 
compared to the effects in 3PC cells. This, together with the increased inhibition of 
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GJIC in 3PC cells under Ca2+e-free conditions, suggests a protecting mechanism of 
Ca2* on the inhibition of GJIC by DDT. 
3PC cells were more sensitive for the inhibition of GJIC by clofibrate compared 
to CA3/7 cells. Although inhibition of GJIC by clofibrate in both 3PC cells and CA3/7 
cells was not dependent on the [Ca2+]e, the increase of [Ca2+]j in 3PC cells was higher 
when [Ca2+]e was higher. In CA3/7 cells, the [Ca2+]; was stronger increased under low 
Ca2+e conditions compared to high Ca2+e conditions. This increased [Ca2+]j under high 
Ca2+e conditions was comparable with the effect of clofibrate on [Ca2+]; in 3PC cells 
under high Ca2+e conditions. The clofibrate-induced increase of [Ca2+]j under low Ca2+e 
conditions was much stronger in CA3/7 cells compared to 3PC cells. The fact that in 
3PC cells GJIC was decreased before significant changes of [Ca2+]j were observed 
suggests that the role of [Ca2+]j in the clofibrate-induced inhibition of GJIC is limited. 
The effect of clofibrate on both GJIC and [Ca2+]; might be the result of reactive oxygen 
products produced in the (clofibrate-stimulated) peroxysomes (18). 
The role of [Ca2+]; in the inhibition of GJIC in 3PC cells by anisidine, limonene, 
and ethionine is not clear. In the first 20 minutes of exposure of 3PC cells to these 
agents the [Ca2+]; was nearly doubled, while the GJIC was inhibited for 70% by 
ethionine and limonene, and only for 25% by anisidine. Furthermore, the changes in 
[Ca2+]j induced by these 3 compounds show no relationship with the effects on GJIC 
during longer exposure times of 3PC cells to these agents. Possible mechanisms by 
which these compounds could inhibit GJIC or change [Ca2+]; are still unknown. 
All together these results show that tumor promoters have different effects on 
[Ca2+]s, and that these effects on [Ca2+]j are not directly related to effects on GJIC, 
except for the effects of DDT in 3PC cells. The finding that tumor promoters have 
different effects on [Ca2*], is additional to the results of our recent study in which 
different effects of tumor promoters were found on Cx43 phosphorylation, Cx43 
location, and E-cadherin location (19). These data point to agent specific mechanisms 
by which tumor promoters inhibit GJIC, not excluding the possibility that some tumor 
promoters might exert their effects by the same mechanism. The differences between 
3PC cells and CA3/7 cells in the sensitivity for inhibition of GJIC by tumor promoters 
can not be explained by the effects of tumor promoters on [Ca2+]j in both cell lines. 
These results also demonstrate that, under different Ca2+e conditions within one cell 
line, GJIC can be inhibited by tumor promoters to the same degree, while different 
effects on [Ca2+]; are induced. This suggests that inhibition of GJIC and a change of 
the [Ca2+]j could be two different, non relating effects of exposure of cells to a tumor 
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promoting agent. For instance, the activation of PKC by TPA could change the Ca2+-
ATPase activity and inhibit GJIC at the same time. Therefore, more research is needed 
to specify the possible role of calcium in tumor promoter-induced inhibition of GJIC. 
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Gap junctional intercellular communication (GJIC) plays an important role in the 
differentiation and growth of cells (1). Increasing evidence also suggests a role for 
inhibition of GJIC in the promotion phase of tumor formation (2-8). How the level of 
GJIC is regulated in normal cells, and if this regulation is changed during the process 
of tumor formation is however not clearly known yet. 
In the chapters 3 and 4 the studies on the regulation of GJIC by (extracellular 
and intracellular) Ca2+- and cAMP-dependent processes are described for a cell line 
consisting of initiated cells (3PC), and a carcinoma derived cell line (CA3/7). From 
these studies it can be concluded that differences exists between the regulation of GJIC 
in cells representing different stages in the process of tumor formation, and that the 
short-term regulation of GJIC by intracellular Ca2+ (Ca2+j) or by cAMP are different 
routes of regulation. Furthermore it can be concluded that the presence of cell adhesion 
molecule E-cadherin on the plasma membrane is a prerequested for a high GJIC level, 
but that E-cadherin is not involved in the short term regulation of GJIC by Ca2+j or 
cAMP. 
The observed differences between 3PC cells and CA3/7 cells in the regulation 
of GJIC by intracellular signals suggest that during the process of tumor formation 
changes have occured in the Ca2+r or calmodulin-dependent regulation of GJIC. These 
differences may be the result of differences in intracellular concentrations of regulating 
molecules (such as Ca2* or CaM) or differences in the sensitivity of enzymes which 
are dependent of Ca2+S or CaM. These differences could result in a blocked intercellular 
communication between cell types representing different stages of tumor formation. For 
instance, if normal cells with a high GJIC level would come in contact with 
preneoplastic cells with different intracellular concentrations of calcium, a diffusion of 
calcium would appear at the moment intercellular gap junctions become functional 
between the two cell types. This diffusion of calcium will then lead to changed 
concentrations in the intracellular gap junction regions, which could result in 
mechanisms closing the gap junction to preserve the cellular homeostasis. Together this 
might lead to a quickly blocked GJIC between the normal and the preneoplastic cells, 
which could have a high homoloques GJIC level, as was shown between transformed 
and non-transformed Balb/c 3T3 cells (9). 
Agents which decrease the level of GJIC (including tumor promoters) can play 
a role in the promotion phase of the process of tumor formation. Several test systems 
(based on the inhibition of GJIC) for the detection of agents with GJIC inhibiting 
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capacity exist (3,4). In these assays however, the target cells for tumor promoters in 
the process of tumor formation (i.e. initiated cells) are not used. From the work 
presented in chapter 5 it can be concluded that a cell line consisting of initiated mouse 
epidermal cells (3PC) is a good model to detect agents with GJIC-inhibiting capacity, 
and that these cells are more sensitive for inhibition of GJIC compared to carcinoma-
derived cells. The sensitivity of primary keratinocytes compared to 3PC cells was 
varying and dependent on the agent used. 
To determine if the differences between the cell types used for the detection of 
inhibition of GJIC (chapter 5) are attributable to differences in mechanisms which are 
thought to play a role in the regulation of GJIC (i.e. connexin amount, connexin 
phosphorylation, connexin location in the cell, E-cadherin amount, and E-cadherin 
location in the cell), we studied the effects of tumor promoters on these parameters in 
the different cell types (chapters 6 and 7). Because calcium plays a role in the 
regulation of GJIC (chapter 3), we also studied the effect of tumor promoters on Ca2* 
and the role of Ca2+e on these effects (chapter 8). From these studies, the following 
conclusions can be drawn: 1) The mechanisms involved in the inhibition of GJIC by 
tumor promoters are agent- and cell type-dependent; 2) The observed differences in the 
susceptibility of cells for the inhibition of GJIC by tumor promoters can not be 
associated with effects of the studied agents on one of the studied parameters; and 3) 
tumor promoters can change [Ca2+]j, but these changes are not associated with 
inhibition of GJIC. 
In addition to the results of the studies on the regulation of GJIC (chapters 3 and 
4), the studies with tumor promoters showed that, in the mouse epidermal cells used 
in these studies, only a decreased immunostaining of Cx43 on the plasma membranes 
of cells can be related to a decreased GJIC level. However, it must be noted that 
specific amino acid analysis of Cx43 could finally demonstrate if a relationship 
between inhibition of GJIC and Cx43 phosphorylation exists et all. 
The mechanisms regulating the transport of connexins to and from the 
membrane, as well as the mechanisms involved in the formation of connexons are yet 
unknown. Because several tumor promoters inhibited GJIC in addition to delocation 
of both Cx43 and E-cadherin, it should be interesting to study the mechanisms 
involved in the assembly of gap junction proteins or cell adhesion molecules in the 
plasma membrane. Such study could lead to a better understanding of the mechanisms 
involved in (chemical-induced) inhibition of GJIC. A study on the time-related changes 
in tumor promoter-induced Cx43 immunostaining and E-cadherin immunostaining 
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could give more insight in the role of E-cadherin in the regulation of GJIC. For such 
a study, also cells transfected with E-cadherin or a connexin could be used. 
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Samenvatting en slotopmerkingen 
Intercellulaire communicatie via gap junctions (GJIC) speelt een belangrijke rol in de 
differentiatie van cellen (1). Aanvullend bewijs suggereert een rol voor remming van 
GJIC in de promotie fase van tumor vorming (2-8). Hoe het GJIC nivo in normale 
cellen is gereguleerd, en of deze regulatie verandert gedurende het proces van tumor 
vorming is echter nog onbekend. 
In de hoofdstukken 3 en 4 van dit proefschrift zijn de studies naar de regulatie 
van GJIC door (intracellulair en extracellulair) Ca2+- en cAMP-afhankelijke processen 
beschreven voor een cellijn afkomstig van gei'nitieerde epidermale cellen van een muis 
(3PC), en van een cellijn afkomstig van een huidcarcinoma van een muis (CA3/7). Uit 
deze studies kan geconcludeerd worden dat verschillen bestaan tussen de GJIC 
regulatie in deze twee cellijnen, en dat de korte termijn regulatie van GJIC door 
intracellulair Ca2+- (Ca2+j) en door cAMP-afhankelijke processen, twee verschillende 
routes van regulatie zijn. Een volgende conclusie is dat de aanwezigheid van het eel 
adhesie molecuul E-cadherin op het plasma-membraan een voorvereiste is voor een 
hoog GJIC nivo. De hoeveelheid van het E-cadherin eiwit of de plaats van E-cadherin 
in de eel zijn echter niet betrokken bij de korte termijn-regulatie van GJIC. 
De gevonden verschillen in de GJIC regulatie door intracellulaire signaal 
moleculen tussen 3PC- en CA3/7-cellen suggereren dat gedurende het proces van 
tumor vorming veranderingen optreden in de Ca2+r of calmoduline (CaM)-afhankelijke 
regulatie van GJIC. Deze verschillen kunnen het gevolg zijn van afwijkende 
intracellulaire concentraties van de signaal moleculen (zoals Ca2* of CaM), of van 
veranderingen in de gevoeligheid van enzymen die afhankelijk zijn van Ca2+r of CaM. 
Deze verschillen kunnen resulteren in een geblokkeerde intercellulaire communicatie 
tussen cellen die in een verschillend stadium van tumor vorming verkeren (heterologe 
communicatie). Indien bijvoorbeeld normale cellen met een hoog GJIC nivo in contact 
komen met getransformeerde cellen, met een andere Ca2+t concentratie, dan zal een 
Ca2+ diffusie optreden op het moment dat gap junctions tussen beide cellen functioneel 
worden. Deze Ca2+ diffusie zal leiden tot veranderde Ca2+ concentraties in de gap 
junction regio's in beide cellen, hetgeen kan resulteren in de activatie van 
mechanismen die GJIC remmen om zo de cellulaire homeostase te bewaren. Dit kan 
uiteindelijk leiden tot een geblokkeerde heterologe communicatie tussen normale- en 
getransformeerde cellen, die beide een hoog homoloog GJIC nivo hebben, zoals 
beschreven voor Balb/c3T3 cellen (9). Het zou daarom interessant zijn om de 
overdracht van een gap junction permeabele (maar membraan inpermeabele) kleurstof 
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te bestuderen tussen kleurstof-bevattende cellen en gecocultiveerde getransformeerde 
cellen, welke normaliter een laag heteroloog GJIC nivo hebben. 
Verbindingen met een GJIC-remmende werking (inclusief tumor promotoren) 
kunnen een rol spelen in de promotie fase van tumor vorming. Verschillende test 
systemen (gebaseerd op de remming van GJIC) bestaan voor de detectie van deze 
verbindingen (3,4). In deze systemen worden de doelcellen voor tumor promotoren 
(gei'nitieerde cellen) echter niet gebruikt. Uit het onderzoek beschreven in hoofdstuk 
5 kan worden geconcludeerd, dat een cellijn bestaande uit gei'nitieerde muis-epidermale 
cellen (3PC) een goed test systeem is voor de detectie van GJIC-remmende 
verbindingen, en dat deze cellen gevoeliger zijn voor GJIC-remming vergeleken met 
een huidcarcimona-afkomstige cellijn. De gevoeligheid van primaire keratinocyten 
varieerde ten opzichte van 3PC cellen afhankelijk van de gebruikte verbinding. 
Om te bepalen of de verschillen in de gevoeligheid voor GJIC remming tussen 
de celtypen (hoofdstuk 5) te herleiden zijn tot verschillen in mechanismen die mogelijk 
een rol spelen in de remming van GJIC (connexin hoeveelheid, connexin fosforylatie, 
connexin locatie in de eel, E-cadherin hoeveelheid en E-cadherin locatie in de eel), 
bestudeerden we de effecten van tumor promotoren op deze parameters in de 
verschillende cellen (hoofdstuk 6 en 7). Daar Ca2+ een rol speelt in de regulatie van 
GJIC (hoofdstuk 3), hebben we ook het effect van tumor promoters op Ca2*, en de rol 
van extracellulair Ca2+ hierop bestudeerd (hoofdstuk 8). Uit deze studie kan het 
volgende worden geconcludeerd: 1) de betrokken mechanismen by de remming van 
GJIC door tumor promotoren zijn afhankelijk van het celtype en van de verbinding; 
2) de verschillen in de gevoeligheid voor GJIC-remming tussen de bestudeerde 
celtypen kan niet geassocieerd worden met effecten van tumor promotoren op een van 
de bestudeerde parameters; 3) de locatie van E-cadherin in de cellen kan door tumor 
promotoren worden veranderd; en 4) tumor promotoren kunnen [Ca2+]; veranderen, 
maar deze veranderingen zijn niet noodzakelijker wijze verbonden met de remming van 
GJIC. 
De studies met de tumor promotoren in muis epidermale cellen tonen aan dat, 
in aanvulling op de resultaten van het onderzoek naar de regulatie van GJIC (hoofdstuk 
3 en 4), alleen een verminderde immunokleuring van connexin43 (Cx43) op het 
plasma-membraan gerelateerd kan worden aan een verlaagd GJIC nivo. Er werd geen 
relatie gevonden tussen andere processen die mogelijk een rol spelen in de regulatie 
van GJIC (inclusief connexin fosforylatie), en remming van GJIC. Aminozuur analyse 
van Cx43 kan echter aantonen of de relatie tussen connexin fosforylatie en GJIC 
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remming tiberhaupt bestaat. 
De mechanismen die het transport van connexins naar- en van het membraan 
reguleren, alsmede de mechanismen betrokken bij connexon vorming zijn vooralsnog 
onbekend. Daar verschillende tumor promotoren GJIC remmen in combinatie met een 
veranderde locatie van zowel Cx43 als E-cadherin, is het interessant om de 
mechanismen te bestuderen die betrokken zijn bij de inbedding van connexins en E-
cadherin in het plasma-membraan. Dit kan leiden tot een verbeterd inzicht in de 
mechanismen die betrokken zijn bij de (chemisch gei'nduceerde) remming van GJIC. 
Een tijd-gerelateerde studie naar de effecten van tumor promotoren op veranderingen 
van de Cx43- en E-cadherin immunokleuring kan meer inzicht geven in de rol van E-
cadherin in de regulatie van GJIC. Cellen getransfecteerd met een connexin of E-
cadherin kunnen mede in dit soort studies nuttige informatie verschaffen. 
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